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ABSTRACT

RNA STRUCTURE AND FUNCTION:
BIOLOGICAL RELEVANCE IN NEURODEGENERATIVE
AND INFECTIOUS DISEASE PATHOGENESIS

By
Joshua A. Imperatore
December 2020

Dissertation supervised by Dr. Mihaela Rita Mihailescu
The studies outlined in this dissertation encompass a broad focus, relating to the
pathogenesis of neurological disorders such as Alzheimer’s disease, fragile X syndrome,
and amyotrophic lateral sclerosis, as well as a novel infectious disease, COVID-19.
However, all four studies detailed within this dissertation contain similar elements, namely,
the coordinated role of RNA structure and function in essential molecular mechanisms.
The results of these investigations allow us to speculate on various disease-related
mechanisms, including dysregulated microRNA processing pathways, nucleocytoplasmic
shuttling via distinct RNA-protein interactions, and fine-tuned molecular switches
controlling genomic dimerization and viral hijacking of host cellular microRNAs. Taken
together, these studies highlight the importance of RNA structure and function in relation
to disease etiology and elucidate previously unknown molecular mechanisms to potentially
be targeted by future therapeutic drug intervention.
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Chapter 1: Background and Motivation
In its most fundamental form, the central dogma of molecular biology explains the
transfer of molecular information from nucleic acids to the protein products which make
up all living things (Crick, 1970). Generally, this data flows in the cell from DNA, the
double-helical biomolecule in which life’s genetic information is stored, to the intermediate
single-stranded messenger RNA (mRNA) via transcription and is subsequently translated
into proteins of diverse functionality. While the understanding of this process and its
components has evolved exponentially since it was first conceived 60 years ago, the
general theory remains unchallenged. However, advances in the field have led to the
discovery that RNA is more than an intermediate step in the central dogma pathway.
Interestingly, of all RNA molecules transcribed from DNA, it is now estimated that less
than 3% encode for proteins (Mattick, 2001). The remaining 97%, termed noncoding
RNAs, are involved in various molecular mechanisms essential for life (Li & Liu, 2019).
To date, at least 7 distinct types of noncoding RNAs have been identified, including
ribosomal RNA, transfer RNA, small nuclear RNA, small interfering RNA, microRNA,
long noncoding RNA, and ribozymes (Figure 1.1). These molecules display an array of
functions, ranging from key components of protein synthesis mechanisms, regulation of
mRNA expression, and even enzymatic activity (Li & Liu, 2019).
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Figure 1.1: Types of RNA molecules and their functions (Li & Liu, 2019).

In order for these various biomolecules to exert their appropriate functions in the
cell, they must be folded into specific conformations. Similar to DNA, RNA has four levels
of structure: primary, secondary, tertiary, and quaternary. The primary structure of RNA is
simply the genetic sequence, composing of four bases (guanine, cytosine, adenine, and
uracil) connected by a sugar-phosphate backbone. This sequence provides the detailed
information for how RNA subsequently folds into diverse secondary structure
conformations that have been identified in the literature, ranging from canonical stem loop
structures to noncanonical G-quadruplexes. Upon secondary structure formation, RNA can
additionally undergo intermolecular and intramolecular interactions, forming tertiary
structures, which includes pseudoknot interactions, triple helix structures, and loop-loop
kissing dimers. Although rare, RNA can lastly incorporate into higher-order quaternary
structures, in most cases complexing with various proteins, to form structures such as
ribozymes and riboswitches. These various levels of RNA structure are crucial to their
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processing,

association

with

RNA-binding

proteins,

and

incorporation

into

ribonucleoprotein complexes. Moreover, numerous studies have demonstrated the effect
of RNA misfolding in disease pathogenesis, whether it be neurodegenerative, infectious,
or cancerous (Cooper et al., 2009). These findings highlight the importance of
understanding the role of RNA structure and function in order to elucidate disease etiology
and aid in future therapeutic drug development. The research presented in this dissertation
investigates some of the potential implications of both coding and non-coding RNA
structures and their functions in the pathogenesis of multiple diseases.
Our first study investigates the secondary structure equilibrium within the guaninerich precursor microRNA-1229, whose mature microRNA product is found upregulated in
Alzheimer’s disease in the presence of a single nucleotide polymorphism (Ghanbari et al.,
2016). These short, 20- to 24-nucleotide noncoding molecules are essential for targeting
mRNAs and regulating their translation. Previous studies have demonstrated that the
formation of noncanonical G-quadruplex structures within guanine-rich precursor
microRNA sequences interferes with protein recognition and processing mechanisms
within the microRNA biogenesis pathway (Arachchilage et al., 2015; Pandey et al., 2015).
We hypothesized that secondary structure equilibrium within precursor microRNA-1229
acts as a fine-tuned molecular mechanism to control mature microRNA-1229 production.
Furthermore, we hypothesized that a single nucleotide polymorphism within precursor
microRNA-1229 linked to Alzheimer’s disease leads to a shift in equilibrium, producing
increased mature microRNA-1229-3p. Using various biophysical techniques, we have
characterized the secondary structures within the precursor sequence and proposed a
molecular mechanism in which the structural equilibrium shifts between canonical stem
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loop and noncanonical G-quadruplex conformations, dysregulating pre-microRNA
processing and aiding in overall disease pathogenesis.
In our second study, we retain focus on the mechanisms of the microRNA
biogenesis pathway, as well as investigate the involvement of the fragile X mental
retardation protein, an RNA-binding protein whose loss of expression is linked to the onset
of fragile X syndrome (Bassell & Warren, 2008; Darnell et al., 2001). Similar to our first
study, we originally hypothesized that the formation of a G-quadruplex structure within the
guanine-rich precursor microRNA-125a affects its interactions with this RNA-binding
protein, leading to altered processing. Furthermore, the state of phosphorylation for the
fragile X mental retardation protein has been shown to alter its interactions with precursor
microRNA molecules, as well as various components of the biogenesis pathway (Cheever
& Ceman, 2009; Muddashetty et al., 2011). We hypothesized that depending on its state of
phosphorylation, these interactions could lead to dysregulation of microRNA processing
and play a role in controlling downstream pathways. The results of this study remain
inconclusive at this time, but preliminary data suggest the possibility of a novel enzymatic
function of the fragile X mental retardation protein, though further studies are required to
determine its validity and significance.
Our research shifts focus for our third study to investigate another RNA-binding
protein, fused in sarcoma, and its interactions with guanine-rich neuronal mRNAs. This
protein is proposed to play roles in mRNA processing, transcription, and
nucleocytoplasmic shuttling, with both familial and sporadic mutations linking it to
amyotrophic lateral sclerosis (Bosco et al., 2010; Lagier-Tourenne et al., 2010; Zinszner et
al., 1997). Building on previous work performed in our lab, we hypothesized that G-
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quadruplex structures within the neuronal PSD-95 and Shank1 mRNAs, whose protein
products are essential for maintaining synaptic plasticity and morphology, are required for
binding to the fused in sarcoma protein and that ALS-linked mutations alter these
interactions (Stefanovic et al., 2015a; Zhang et al., 2014). Our results demonstrate that the
noncanonical G-quadruplex structures within these RNA molecules are per se sufficient
for their interactions with the fused in sarcoma protein and that an ALS-linked truncation
of the protein inhibits this binding. We speculate that these interactions are necessary for a
novel molecular mechanism in which specific RNA secondary structures are required for
protein binding and subsequent nucleocytoplasmic shuttling to the synapse for local
translation, a process which could be hindered in the pathogenesis of amyotrophic lateral
sclerosis.
Lastly, our fourth study investigates the role of dimeric RNA-RNA interactions
within a conserved stem-loop element of the SARS-CoV-2 genome. The function of this
element remains elusive, but its conservation among multiple viral families indicates it
confers a selective advantage (Caly et al., 2020; Tengs & Jonassen, 2016). Contained
within the terminal loop of this element is a 4-nucleotide palindrome, which we propose
mediates homodimeric kissing dimer formation. We propose that the viral nucleocapsid
protein is able to aid in the conversion of this kissing dimer intermediate structure to a
stable, extended duplex, as has been shown in other viral systems (Mihailescu & Marino,
2004; Shetty et al., 2010). Moreover, bioinformatic analysis of the SARS-CoV-2 genome
revealed multiple binding sites for cellular microRNA-1307-3p within this highly
conserved element, which we hypothesize could be involved in the onset of the “cytokine
storm” seen in severe COVID-19 patients (Arisan et al., 2020; Mehta et al., 2020). Our
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results demonstrate the ability of this element to dimerize into both kissing dimer and
extended duplex conformations, with the conversion aided by the viral nucleocapsid
protein. We also show that the element interacts with multiple copies microRNA-1307-3p,
a process which is mediated by genome dimerization. We speculate on the potential for
targeting this apparent molecular switch in future therapeutic drug development studies as
a way of preventing certain viral mechanisms, such as homologous recombination events,
as well as potentially alleviating severe COVID-19 symptoms.
Taken together, the research presented in this dissertation highlights the importance
of better understanding how RNA structure affects its molecular functions, such as
interactions with various proteins and other RNAs, both coding and noncoding. Our results
add to the breadth of knowledge in various fields on how RNA structure and function could
be important in neurodegenerative and infectious disease pathogenesis, and we propose
numerous molecular mechanisms through which specific RNA structures could be targeted
in future therapeutic development studies.

6

Chapter 2: Characterization of a G-Quadruplex Structure in Pre-miRNA-1229 and
in its Alzheimer’s Disease-Associated Variant rs2291418: Implications for miRNA1229 Maturation
Chapter 2.1 Introduction. Alzheimer’s disease (AD) is the most common age-related
neurodegenerative disease, currently affecting an estimated 4.7 million people in the
United States alone, with that number expected to nearly triple to a projected 13.8 million
by the year 2050 (Hebert et al., 2013). The disease is characterized by cognitive declines
such as progressive memory loss, confusion, and disorientation, as well as behavioral and
mood changes (Förstl & Kurz, 1999). It is widely accepted that AD is also a leading cause
of dementia in older individuals (Barker et al., 2002; Wilson et al., 2012). At a molecular
level, the development of AD can be associated with the accumulation of filamentous tau
tangles inside of neurons and of beta amyloid (Aβ) plaques extracellularly. The
accumulation of these proteins interferes with proper neuron-to-neuron communication at
synapses in AD, resulting in disrupted transmission of information and eventual cell death
(Selkoe, 2010).
Aβ is generated by endoproteolytic cleavage of the transmembrane amyloid
precursor protein (APP) into a 40–42 amino acid fragment (Glenner & Wong, 1984;
Iwatsubo et al., 1994). While the main function of APP has not yet been determined, it is
generally accepted that dysregulation of its processing is a major factor in the development
of the neurotoxic Aβ deposits in AD (Hardy & Higgins, 1992). It has been suggested that
this may occur due to missense mutations within APP, resulting in an increased production
of Aβ42, the longer and more amyloidogenic variant that has an increased prevalence in AD
patients (Citron et al., 1992; Suzuki et al., 1994). However, another possibility is that the
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dysregulation of various other proteins involved in this process may impair proper cleavage
and trafficking of APP. Genome-wide association (GWAS) studies have determined a
comprehensive list of genes associated with AD, including those that encode for
apolipoprotein E (Strittmatter et al., 1993), death-associated protein kinase 1 (Li et al.,
2006), interleukin 8 (Li et al., 2009), transferrin (van Rensburg et al., 1993), and sortilinrelated receptor (Ciarlo et al., 2013). The latter of these proteins, abbreviated SORL1, is a
multifunctional membrane-bound receptor protein expressed throughout the brain that
plays roles in cell-to-cell signaling and vesicle trafficking (Jacobsen et al., 1996; Motoi et
al., 1999). Recent studies have reported that SORL1 functions to direct APP into recycling
pathways under normal conditions. However, the downregulation of SORL1 expression
results in APP being sorted into Aβ-generating pathways, demonstrating a potential
mechanistic function of SORL1 in AD pathogenesis (Rogaeva et al., 2007). Inherited
genetic variants within SORL1 mRNA that are associated with AD have been shown to
downregulate SORL1 protein translation (Rogaeva et al., 2007).
Other molecular mechanisms, such as microRNA (miRNA) dysregulation, have
also been proposed to be involved in AD pathogenesis (Idda et al., 2018; Tan et al., 2013).
miRNAs are a class of short, noncoding RNAs approximately 20–24-nucleotides in length
which bind to complementary “seed regions” within the 3′ untranslated region (UTR) of
mRNAs and regulate their translation (Bartel, 2009). Mature miRNAs are produced via a
distinct biogenesis pathway, beginning with the transcription of miRNA genes to produce
the primary miRNA (pri-miRNA), which is further processed by the ribonuclease III
enzyme Drosha and the protein DiGeorge syndrome critical region 8 (DGCR8) into
precursor miRNAs (pre-miRNAs), 70–90-nucleotide sequences that contain a 2-nucleotide
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overhang on their 3′ end (Figure 2.1) (Han et al., 2004; Lee et al., 2003; Lee et al., 2004).
The pre-miRNAs, proposed to fold into extended stem loop structures, are exported to the
cytoplasm in a Ran-GTP energy-driven process by the nucleocytoplasmic shuttling protein
Exportin-5, which recognizes their 3′ overhang (Yi et al., 2003). In the cytoplasm, the
endoribonuclease III enzyme Dicer recognizes the pre-miRNA stem-loop structure,
cleaving off the terminal loop and yielding an imperfect double-stranded miRNA:miRNA*
duplex (Bernstein et al., 2001; Hutvágner et al., 2001). Dicer further associates with various
other proteins to form the RNA-induced silencing complex (RISC), including Argonaute2
(AGO2) and human immunodeficiency virus (HIV) transactivating response RNA (TAR)
binding protein (TRBP) (Chendrimada et al., 2005; Yoda et al., 2010). While the mature
miRNA remains incorporated in the miRNA:RISC complex, the opposite strand, or
passenger strand (miRNA*), is discarded (Khvorova et al., 2003). The miRNA-guided
RISC complex subsequently recognizes and binds to mRNA targets, leading to mRNA
cleavage and/or translational repression.

9

Figure 2.1: Schematic representation of the miRNA pathway.

The importance of regulating miRNA levels has been demonstrated in a multitude
of studies, with dysregulated levels being associated with various diseases, such as AD
(Amakiri et al., 2019), Down syndrome (Brás et al., 2018), and many cancers (Paul et al.,
2018). It has been proposed that the formation of alternative secondary structures in premiRNAs can affect their processing by Dicer and thus, the mature miRNA production
within the cell (Arachchilage et al., 2015; Pandey et al., 2015). Bioinformatic studies have
concluded that 13%–16% of all human pre-miRNA sequences contain guanine-rich (Grich) regions that have the potential to form G-quadruplex (GQ) structures (Arachchilage
et al., 2015; Pandey et al., 2015). GQs are noncanonical secondary structures formed by
stacking of two or more cyclic, planar G-quartet arrangements of four guanine residues and
stabilized by Hoogsteen-type hydrogen bonds, π-π stacking interactions, and intercalating
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monovalent cations (Figure 2.2) (Williamson, 1994; Williamson et al., 1989). The
formation of these GQ structures within G-rich pre-miRNAs has been proposed to inhibit
their processing by Dicer due to the lack of a terminal stem loop. Among the pre-miRNAs
with G-rich sequences which have the potential to form GQ structures is pre-miRNA-1229,
whose mature miRNA product, miRNA-1229-3p, has recently been shown to directly
control the expression of SORL1 (Ghanbari et al., 2016). Moreover, Ghanbari et al.
performed a GWAS which demonstrated that an allelic guanine to adenine rs2291418
variant (cytosine to uracil in the RNA) within pre-miRNA-1229 is associated with AD and
that this single nucleotide polymorphism (SNP) enhances the production of miRNA-12293p, while decreasing the expression levels of SORL1 (Ghanbari et al., 2016).

Figure 2.2: Schematic representation of GQ secondary structures. Cyclic, planar G-quartet arrangements
consisting of four guanine residues (A) stack upon one another to form noncanonical GQ structures (B).

In this study, we utilized various biophysical techniques to show that a GQ structure
forms in pre-miRNA-1229 which coexists in equilibrium with the canonical extended stem
loop structure. Furthermore, characterization of the rs2291418 variant demonstrated a shift
in equilibrium towards the extended stem loop structure (Imperatore et al., 2020a). These
results suggest that a fine-tuned molecular mechanism controls mature miRNA-1229-3p
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production and that its dysregulation leads to the increased production of the mature
miRNA-1229-3p in AD. Moreover, these results raise the possibility of utilizing the GQ
structure within pre-miRNA-1229 as a potential therapeutic target in AD, as has been
suggested in other disease systems (Balasubramanian & Neidle, 2009).

Chapter 2.2 The G-rich Region of Pre-miRNA-1229 Folds into a GQ Structure. The
formation of GQ structures in G-rich pre-miRNA sequences has been proposed to alter the
efficiency of miRNA production (Arachchilage et al., 2015; Pandey et al., 2015). Since
pre-miRNA-1229 has multiple G-tracts, (Table 2.1, numbered 1 to 6 in Figure 2.3A), we
used the online QGRS Mapper software, which predicted that a three-plane GQ structure
can form in this pre-miRNA using the G-tracts 2, 3, 4, and 5 (Figure 2.3A and 2.3C) (Kikin
et al., 2006). To determine if this G-rich region of pre-miRNA-1229 indeed folds into the
predicted GQ structure, we initially investigated a truncated sequence spanning nucleotides
1–42 of pre-miRNA-1229 that contains the six G-tracts that could participate in GQ
structure formation (named pre-miRNA-1229_WT GQ, Table 2.1).
pre-miRNA-1229_WT GQ
pre-miRNA_1229_WT FL

5′ GGG UA GGG UUU GGGGG AGAG C GU GGG CU GGGG
UUCA GGG ACA 3′
5′ GGU GGG UA GGG UUU GGGGG AGAG C GU GGG CU
GGGG UUCA GGG ACA CCC UCU CAC CAC UGC CCU CCC
ACA G 3′

Table 2.1: Pre-miRNA-1229 sequences. G-rich areas within pre-miRNA sequences with potential to form
GQ structures are underlined and bolded. The SNP mutation locations are highlighted in red and italicized.
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Figure 2.3: Predicted secondary structures of pre-miRNA-1229 sequences. RNA Structure prediction
software was used to determine the most likely stem loop structures for full-length pre-miRNA-1229_WT (A)
and pre-miRNA-1229_SNP (B) (Reuter & Mathews, 2013). G-tracts are numbered and highlighted by red
boxes. The location of the SNP is indicated with an arrow in both structures. The predicted GQ structure of
full-length pre-miRNA-1229 was determined using the online QGRS Mapper software (C) (Kikin et al.,
2006). Nucleotides involved in GQ formation are colored according to the legend below and the location of
SNP is indicated with an arrow.

We first characterized pre-miRNA-1229_WT GQ RNA using 1D 1H NMR
spectroscopy, focusing on the imino proton resonance region between 10 and 15 ppm and
titrating increasing KCl concentrations in the range of 0–150 mM, as K+ ions stabilize GQ
structures (Figure 2.4A) (Williamson, 1994; Williamson et al., 1989). Broad resonances
are apparent even at 0 mM KCl in the 10–12 ppm region corresponding to guanine imino
protons involved in Hoogsteen base pairs in GQ structures (Fürtig et al., 2003). Another
resonance is also evident around 13.3 ppm, within the imino proton region 12–14.5 ppm
assigned to imino protons involved in Watson–Crick base pairs (Figure 2.4A, bottom
spectrum) (Fürtig et al., 2003). We hypothesize that this resonance arises from Watson–
Crick loop–loop interactions within the GQ structure. Increasing KCl concentrations do
not seem to have an effect on the intensity of the resonances in the GQ region (Figure
2.4A), indicating that a GQ structure is stably formed even in the absence of K+. RNA
sequences have been shown to form stable GQ structures even in the absence of K+ ions,
13

while these ions are required for GQ formation in DNA of identical sequence (Joachimi et
al., 2009).

Figure 2.4: Biophysical characterization of the truncated pre-miRNA-1229_WT GQ sequence. 1H NMR
spectroscopy (A) and CD spectroscopy (B) experiments were performed with increasing concentrations of
KCl titrated into the sample. UV thermal denaturation experiments were performed over a range of RNA
concentrations and hypochromic transitions (C) were fit using Equation (1) (Materials and Methods) in
OriginPro data analysis software. Calculated Tm values (Equation (3), Materials and Methods) were plotted
as a function of the RNA concentration (D). Nondenaturing gel electrophoresis (E) experiments were
performed with increasing concentrations of KCl and visualized by UV shadow (left panel) prior to staining
with the GQ-specific NMM dye (right panel).

While both parallel and anti-parallel GQ structures have been observed in DNA,
RNA GQs typically only adopt a parallel directionality (Miyoshi et al., 2003). To determine
the directionality of the GQ structure in pre-miRNA-1229_WT GQ, circular dichroism

14

(CD) spectroscopy experiments were performed. Parallel GQ structures show a positive
band at ~265 nm and a negative band at ~240 nm, whereas the signatures of an antiparallel
GQ are a positive band at ~295 nm and a negative band at ~260 nm (Miyoshi et al., 2003).
Our results confirm that a parallel GQ forms within pre-miRNA-1229_WT GQ, as a
positive band at ~265 nm was observed with a negative band at ~240 nm. Moreover, the
intensity of these bands changes minimally as the KCl concentration is increased (Figure
2.4B), consistent with the 1H NMR spectroscopy results (Figure 2.4A), indicating that the
GQ structure formed by pre-miRNA-1229_WT GQ is stable even in the absence of K+
ions. Helical structures in A-RNA give rise to a positive band at 260 nm, a negative band
at 210 nm, and a small negative CD between 290 and 300 nm (Ranjbar & Gill, 2009). A
low intensity negative band was observed at ~210 nm, however, since the intensity of this
band is too low with respect to that of the positive band at 260 nm and we did not observe
the small negative CD between 290 and 300 nm, we rule out the formation of a stem loop
structure in pre-miRNA-1229_WT GQ (Ranjbar & Gill, 2009). Similar to the 1H NMR
spectroscopy single resonance at 13.3 ppm, we assign the origin of the 210 nm small
intensity band to Watson–Crick loop–loop interactions within the GQ structure.
To determine the overall stability of the GQ structure formed in pre-miRNA1229_WT GQ, UV thermal denaturation experiments were performed at 295 nm, a
wavelength sensitive to GQ structure dissociation, at a fixed KCl concentration of 150 mM
and a range of RNA concentrations from 5 to 50 μM (Mergny et al., 1998). At all RNA
concentrations investigated, a single hypochromic transition corresponding to the
unfolding of a GQ structure was observed (data not shown). The melting temperature (Tm)
of the GQ structure at each RNA concentration was determined to be ~80 °C at all RNA
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concentrations investigated (Figure 2.4D) by fitting the hypochromic transition using
Equations (1) and (3) (Materials and Methods), suggesting that pre-miRNA-1229_WT
GQ forms an intramolecular GQ structure (Hardin et al., 2000; Menon et al., 2008; Zhang
et al., 2014).
Finally, pre-miRNA-1229_WT GQ was analyzed by 20% nondenaturing
polyacrylamide gel electrophoresis at various KCl concentrations in the range of 0–150
mM (Figure 2.4E). A main band was observed at each KCl concentration when the gel
was visualized by UV shadowing (Figure 2.4E, left panel) (Hendry & Hannan, 1996). This
band stained in N-methyl mesoporphyrin IX (NMM), a GQ-specific dye (Figure 2.4E,
right panel), revealing that it corresponds to a GQ structure (Arthanari et al., 1998).
Additionally, a lower band became clearly visible in the NMM stained gel, indicating the
formation of an alternate GQ structure. While Figure 2.3C depicts the most stable GQ
structure predicted by the QGRS Mapper software, multiple GQ structures could be formed
in pre-miRNA-1229_WT GQ because it contains six G-tracts and only four of these are
required for the formation of a GQ structure (Arachchilage et al., 2015; Kikin et al., 2006;
Pandey et al., 2015). A negative control RNA that cannot form a GQ structure (NoGQ)
was visible when the gel was visualized by UV shadowing (Figure 2.4E, left panel), but
absent when stained with NMM (Figure 2.4E, right panel) (Arthanari et al., 1998; Hendry
& Hannan, 1996).
Taken together, the results from these biophysical studies confirm the formation of
a parallel, intramolecular GQ structure with a Tm of ~80 °C in 150 mM KCl in the truncated
pre-miRNA-1229_WT GQ sequence.
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Chapter 2.3 Full-Length Pre-miRNA-1229 Forms a GQ Structure That Coexists in
Equilibrium with an Extended Stem Loop. To investigate whether the GQ structure
formed by the G-rich region of pre-miRNA-1229 is retained within the full-length premiRNA-1229_WT sequence (named pre-miRNA-1229_WT FL, Table 2.1), in which
additional nucleotides past position 42 compete for the formation of the canonical extended
stem loop structure, 1D 1H NMR spectroscopy experiments were performed to monitor
secondary structure formation by observing the imino proton resonance region at
increasing concentrations of KCl (Figure 2.5A). Multiple resonances between 12 and 14.5
ppm, which indicate the formation of a stem loop structure, were observed for pre-miRNA1229_WT FL, these resonances being absent in pre-miRNA-1229_WT GQ (compare
Figures 2.4A and 2.5A) (Fürtig et al., 2003). The broadness of these resonances could be
due to the size of the RNA investigated, but it could also indicate possible exchange
between different conformations. Sharper resonances on a broad envelope background
were also observed in the range of 10–12 ppm. As discussed above, resonances in the range
of 10–12 ppm are assigned to guanine imino protons involved in Hoogsteen base pairs in
GQ structures (Fürtig et al., 2003). However, in sequences that cannot form GQ structures,
sharper resonances in these regions were assigned to GU wobble base pairs or side-by-side
GG/GA base pairs, while broader resonances were assigned to unpaired G or U imino
protons located in loop regions (Glemarec et al., 1996; Shankar et al., 2006). Moreover,
although Watson–Crick imino protons are observed typically in the range of 12–14.5 ppm,
there are instances where the imino proton of a guanine involved in a GC base pair
immediate to an internal loop could give rise to a resonance around 11.9 ppm (Glemarec
et al., 1996). Indeed, the predicted extended stem loop structure of pre-miRNA-1229_WT
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FL contains side-by-side G and A residues within an internal loop, unpaired G and U
residues in the terminal loop, and GC Watson–Crick base pairs immediately adjacent to
internal loops (Figure 2.3A), all of which could give rise to the sharper resonances
observed in the 10–12 ppm region. The presence of a broader envelope resonance centered
around 11 ppm, visible especially upon addition of higher KCl concentrations, suggests the
presence of a GQ structure as well (Figure 2.5A). However, the GQ structure signatures
become clearly visible only once the sample is annealed in the presence of 150 mM KCl,
as the intensity of the broad resonance around 11 ppm increases with the concomitant
decrease of the resonances in the Watson–Crick imino proton region (Figure 2.5A, top
spectrum). These results indicate that pre-miRNA-1229_WT FL forms a GQ structure
coexisting in equilibrium with a stem loop structure, with the GQ structure being stabilized
by annealing the RNA in the presence of KCl.
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Figure 2.5: Biophysical characterization of the full-length pre-miRNA-1229_WT FL sequence. 1H NMR
spectroscopy (A) and CD spectroscopy (B) experiments were performed with increasing concentrations of
KCl titrated into the sample. UV thermal denaturation experiments were performed over a range of RNA
concentrations with hypochromic transitions (C) fit using Equation (1) (Materials and Methods) in
OriginPro data analysis software. Calculated Tm values were determined using Equation (3) (Materials and
Methods). Nondenaturing gel electrophoresis (D) experiments were performed with increasing
concentrations of KCl and visualized by UV shadow (left panel) prior to staining with the GQ-specific NMM
dye (right panel).

CD spectroscopy experiments were next performed for pre-miRNA-1229_WT FL
at varying KCl concentrations in the range of 0–150 mM (Figure 2.5B), revealing a
positive band at ~265 nm, a negative band at ~235 nm, an intense negative band at 210 nm,
and a small negative CD between 290 and 300 nm. These bands, which did not change
significantly with the KCl titrations, are consistent with the presence of both a stem loop
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and a GQ structure coexisting in equilibrium (Joachimi et al., 2009; Miyoshi et al., 2003).
Additionally, consistent with 1H NMR spectroscopy results (Figure 2.5A, top spectrum),
only when the sample was annealed at 95 °C in 150 mM KCl was a significant difference
observed in the CD spectrum, with an increase in the intensity of the positive band at ~265
nm and a decrease in the intensity of the negative band at ~210 nm, indicating a shift of the
equilibrium towards the GQ structure.
UV thermal denaturation experiments were performed at 295 nm to determine the
stability of the GQ structure formed within the pre-miRNA-1229_WT FL sequence
(Mergny et al., 1998). A hypochromic transition corresponding to GQ structure
dissociation was observed between 79 and 95 °C, with a hyperchromic transition
corresponding to the stem loop structure dissociation observed between 46 and 79 °C
(Figure 2.5C). These experiments were performed in the presence of 100 mM KCl, as the
GQ structure was too stable at 150 mM KCl, resulting in an incomplete hypochromic
transition (data not shown). The GQ dissociation transition was fit using Equations (1)
and (3) (Materials and Methods) (Figure 2.5C) and a Tm of ~85 °C was determined (Menon
et al., 2008; Zhang et al., 2014).
The equilibrium between the stem loop and GQ structures in pre-miRNA1229_WT FL was further characterized by 15% nondenaturing gel electrophoresis in the
presence of various concentrations of KCl (Figure 2.5D). When the gel was visualized by
UV shadowing, a single main band was evident at all concentrations of KCl, with very
faint upper bands also apparent (Figure 2.5D, left panel) (Hendry & Hannan, 1996). When
the gel was stained in the GQ-specific NMM dye, the main band stained, as well as multiple
upper bands and a lower band, which also became clearly visible (Figure 2.5D, right
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panel), indicating the presence of multiple GQ structure conformations due to the presence
of six G-tracts in the sequence (Figure 2.3A), as well as possible stacking interactions
between GQ structures (Arthanari et al., 1998).
The results from these biophysical characterization studies show that GQ structures
are retained in the context of the full-length pre-miRNA-1229_WT FL sequence, which
coexist in equilibrium with the canonical extended stem loop structure. Additionally, while
the GQ structure can form in the absence of K+ ions, it is stabilized by annealing the RNA
in the presence of 150 mM KCl (Figure 2.5A).
To monitor the equilibrium between the GQ and stem loop structures in ionic
conditions closer to physiological conditions, 1 mM MgCl2 was added to the NMR sample
previously annealed in the presence of 150 mM KCl (Figure 2.6A, bottom spectrum),
acquiring time-dependent spectra over the course of 6 days, during which time the sample
was incubated at 37 °C (Figure 2.6). Mg2+ ions stabilize various RNA structures, including
stem loops, and this was observed for pre-miRNA-1229_WT FL since the imino proton
resonances corresponding to Watson–Crick base pairs become sharper over time (Figure
2.6A) (Fürtig et al., 2003; Serra et al., 2002). However, it is interesting to note that the
broad resonances centered around 11 ppm, corresponding to guanine imino protons
engaged in Hoogsteen base pairs in the GQ structure, increase in intensity, suggesting an
equilibrium shift in which folding of the GQ structure is preferred over time (Figure 2.6A
and overlay of spectra in Figure 2.6B).
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Figure 2.6: Time-dependent 1H NMR spectra of full-length pre-miRNA-1229_WT FL. The sample was
incubated in the presence of 150 mM KCl and 1 mM MgCl2 at 37 °C (A) with spectra acquisition occurring
over a 6-day period. An overlay of the spectra is shown in (B).

Chapter 2.4 The GQ Structure Formed Within Pre-miRNA-1229 is Retained in the
AD-Associated rs2291418 Variant. Ghanbari et al. demonstrated not only that miRNA1229 is implicated in AD by regulating the translation of SORL1, but also that the premiRNA-1229 variant rs2291418 (cytosine to uracil in the RNA, indicated by arrows in
Figure 2.3), which results in increased levels of mature miRNA-1229-3p, is associated
with AD (Ghanbari et al., 2016). Given that the rs2291418 SNP is located within the Grich region of pre-miRNA-1229 (arrows in Figure 2.3A–C), we hypothesized that this
variant could potentially shift the equilibrium between the GQ and stem loop structures
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within pre-miRNA-1229 and consequently dysregulate the control of the mature miRNA1229 production.
Characterization of the truncated, 42-nucleotide pre-miRNA-1229 rs2291418
variant revealed the formation of a parallel, intramolecular GQ structure, with a Tm of ~78
°C (Imperatore et al., 2020a). Interestingly, 1H NMR and CD spectroscopy analysis
suggested the absence of loop-loop interactions seen within the wild-type pre-miRNA1229_WT GQ sequence. The full-length pre-miRNA-1229 sequence containing the ADassociated rs2291418 variant was subsequently characterized by similar biophysical
techniques, revealing an equilibrium between an extended stem loop structure and a
parallel, intramolecular GQ with comparable stability (Imperatore et al., 2020a). Timedependent 1H NMR spectroscopy studies of the full-length pre-miRNA-1229 ADassociated variant were subsequently performed, demonstrating a shift in equilibrium
towards the extended stem loop over time (Imperatore et al., 2020a). Taken together, the
results from this study add to the growing number of G-rich pre-miRNA sequences shown
to form GQ structures that could interfere with their recognition and processing by Dicer
to produce mature miRNAs, ultimately providing a fine-tuned mechanism for regulating
target mRNA translation (Arachchilage et al., 2015; Pandey et al., 2015).

Chapter 2.5 Discussion. Ghanbari et al. proposed that the increased levels of miRNA1229-3p in pre-miRNA-1229 containing the AD-associated rs2291418 variant are due to
the stabilization of the stem loop structure by the SNP. In the study, they predicted that the
minimum free energy of the SNP stem loop was ΔG° = −36.10 kcal/mol, whereas that of
the WT was ΔG° = −31.90 kcal/mol (Ghanbari et al., 2016). However, when we folded the
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pre-miRNA-1229_WT FL and pre-miRNA-1229_SNP FL sequences with the
RNAstructure software (Figure 2.3A and Figure 2.3C), the two stem loop structures were
predicted to have free energies of ΔG° = −36.0 kcal/mol and ΔG° = −36.7 kcal/mol,
respectively, which differ only by 0.7 kcal/mol (Reuter & Mathews, 2013). The results of
our study demonstrated that the wild-type pre-miRNA-1229 sequence forms a GQ structure
that coexists in equilibrium with the canonical extended stem loop structure, similar to that
of the AD-associated rs2291418 variant (Imperatore et al., 2020a). Destabilization of the
GQ structure in the rs2291418 variant, possibly due to the lack of loop–loop interactions,
results in a shift of this equilibrium towards the stem loop structure, potentially allowing
for increased recognition and processing by Dicer.
Investigating the molecular pathways and key mechanistic steps involved in AD
pathogenesis is vital for the development of therapeutic interventions for the disease.
Research in the field has shifted focus to the involvement of noncoding miRNAs in AD
due to their contributions in regulating gene expression, Aβ and tau protein maintenance,
inflammation, and cell death (Idda et al., 2018; Tan et al., 2013). A recent study by Ke et
al. suggested that miRNA-107 plays a neuroprotective role in AD progression and that its
expression levels are reduced in an Aβ-induced AD model (Ke et al., 2019). Furthermore,
the authors of this study propose a mechanism in which the long noncoding RNA (lncRNA)
NEAT1 binds to miRNA-107, leading to this downregulation. In this study, we investigated
pre-miRNA-1229 due to its guanine-rich regions with the potential to form GQ structures,
as well as the association of the rs2291418 variant with AD and subsequent upregulation
of miRNA-1229-3p production. We successfully characterized a novel GQ structure within
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the sequence which has the potential to function as a therapeutic target for AD
(Balasubramanian & Neidle, 2009; Ghanbari et al., 2016).
However, the results of this study have implications beyond the AD context, as
multiple studies have determined that the upregulation of mature miRNA-1229 can be
associated with various other diseases. Expression levels of miRNA-1229 were found to
be correlated with increased severity of coronary artery calcification, as well as increased
tumor size in colorectal cancer (Hu et al., 2019; Liu et al., 2015). Furthermore, miRNA1229 overexpression has also been proposed to promote cell proliferation and
tumorigenicity in breast cancer (Tan et al., 2016).
This study proposes a mechanism in which the pre-miRNA-1229 equilibrium
between GQ and extended stem loop structures is altered in the rs2291418 variant,
potentially explaining the increased mature miRNA-1229-3p production observed in the
AD-linked variant (Figure 2.7) (Imperatore et al., 2020a). These results warrant further
investigation into how RNA structure can have downstream effects in disease
pathogenesis, and ultimately how GQ structures, such as those found in pre-miRNA-1229,
could be therapeutically targeted for intervention purposes in the future.

Figure 2.7: Proposed mechanism of miRNA-1229 dysregulation in the pathogenesis of Alzheimer’s disease.
Shift in equilibrium from GQ to stem loop in the AD-associated rs2291418 variant of pre-miRNA-1229 results
in increased mature miRNA-1229 levels, leading to decreased SORL1 levels and subsequent increased Aβ42
production.
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Chapter 3: Determining the Effect of FMRP ISO1 and its Phosphomimic Isoform
(S500D) on Pre-miRNA-125a Biogenesis
Chapter 3.1 Introduction. Fragile X syndrome (FXS) is the most common form of
inherited mental impairment, affecting ~1 in 4,000 males and ~1 in 8,000 females
(Crawford et al., 2015). Common symptoms of the disease include learning disabilities,
cognitive impairment, and physical abnormalities such as long and narrow faces, large ears,
and prominent jaws and foreheads (Darnell et al., 2001; Jin & Warren, 2000). The
syndrome is the result of a cytosine-guanine-guanine (CGG) repeat expansion in the 5’
UTR of the fragile X mental retardation-1 (FMR1) gene. Approximately 6-40 of these
repeats are found in the FMR1 gene in normal individuals, 61-200 in individuals with the
premutation, and the trinucleotide repeat is expanded more than 200 times in individuals
with the full mutation (Bassell & Warren, 2008; Crawford et al., 2015; Jacquemont et al.,
2007). The largest expansion causes hypermethylation of the cytosine residues, leading to
transcriptional silencing of the FMR1 gene and loss of function of the fragile X mental
retardation protein (FMRP) (Pieretti et al., 1991; Tassone et al., 1999). This loss of function
is suggested to be one of the main causes of FXS, while intermediate expansions have been
associated with both fragile X-associated tremor ataxia syndrome (FXTAS) and fragile Xassociated primary ovarian insufficiency (FXPOI) (Jacquemont et al., 2004; Sullivan et al.,
2011).
The FMR1 gene is able to undergo alternative splicing within its 17 exons,
involving exons 12 and 14 and the choice of alternative acceptor sites within exon 15
(Brackett et al., 2013). These splicing mechanisms result in at least twelve expressed
isoforms of FMRP, including the full-length protein, isoform 1 (ISO1) (Figure 3.1). Of
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these twelve isoforms, only half incorporate exon 12 into their mature mRNA product, with
those lacking the region (isoforms 7-12) resulting in a truncated variable loop between β2
and β’ strands of the second K-homology (KH2) RNA-binding domain (Brackett et al.,
2013; Valverde et al., 2007). The extended variable loop within the KH2 domain of FMRP
isoforms 1-6 forms the canonical RNA-binding cleft, while the truncated loop in isoforms
7-12 has been shown to interact with RNA kissing complex structures and mediate
interactions between FMRP and certain mRNA targets (Darnell et al., 2005; Valverde et
al., 2007). Interestingly, RNA expression level studies indicated that all FMR1 transcript
isoforms are produced in equal levels during early embryonic development, followed by a
significant shift in postnatal and adult mice, with those that lack exon 12 becoming the
dominant transcripts (Brackett et al., 2013).

Figure 3.1: Schematic representation of FMRP. Starting at the N-terminus, FMRP contains a tandem Agenet
(Tudor) domain (Age1 and Age2), nuclear localization signal (NLS), three K-homology domains (KH0, KH1,
and KH2), a nuclear export signal (NES), and an arginine-glycine-glycine rich region (RGG). Locations of
phosphorylation are highlighted by a red “P” and arrows in the expanded sequence (S497, S500, S504).
Truncation of the KH2 domain in isoforms 7-12 is highlighted in the expanded sequence (top).

Contained within FMRP are various other recognized domains, including a Cterminal nuclear localization signal (NLS) and an N-terminal nuclear export signal (NES),
both of which are essential for its proposed role as a nucleocytoplasmic shuttling protein,
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as well as a tandem Agenet (Tudor) domain (Age1 and Age2), believed to be important for
protein-protein interactions (Bardoni et al., 1999; Feng et al., 1997; Myrick et al., 2015).
Furthermore, three other RNA-binding domains, in addition to KH2, have been identified
within FMRP: two additional KH domains (KH0 and KH1) and one arginine-glycineglycine (RGG) domain (Figure 3.1) (Ashley et al., 1993; Darnell et al., 2001). The latter
of these domains specifically recognizes and interacts with GQ structures within the 3’ or
5’ UTR of guanine-rich neuronal mRNA targets (Brown et al., 2001; Menon & Mihailescu,
2007; Schaeffer et al., 2001; Stefanovic et al., 2015b; Zhang et al., 2014). These
interactions have been suggested to facilitate the role of FMRP in mRNA transport,
stabilization, and metabolism, specifically by regulating the translation of their target GQforming mRNAs (Darnell et al., 2001; Melko & Bardoni, 2010).
FMRP can additionally undergo posttranslational modifications such as arginine
methylation and phosphorylation on specific serine residues. The primary FMRP site of
phosphorylation has been identified at serine 500, with secondary phosphorylation sites
proposed to be at serine residues 497 and 504 (Figure 3.1) (Ceman et al., 2003; Coffee et
al., 2012). Phosphorylation is believed to be mediated by protein phosphatase 2A (PP2A)
suppression in an mTOR-dependent manner upon sustained metabotropic glutamate
receptor (mGluR) activation (Narayanan et al., 2007). Various kinases have also been
suggested to play roles in this phosphorylation event, including ribosomal S6 kinase
(S6K1) and casein kinase II (CK2), but further studies are required to determine the specific
proteins involved (Bartley et al., 2014; Narayanan et al., 2007). Nonetheless, mGluRdependent phosphorylation of FMRP has been widely accepted to be required for
translational repression of target mRNAs, whereas dephosphorylation triggers their
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translation (Ceman et al., 2003; Narayanan et al., 2007). This mechanism has been
demonstrated with FMRP recruitment of the miRNA-125a – AGO2 complex to the GQcontaining 3’ UTR of PSD-95 mRNA, resulting in its translational repression (DeMarco et
al., 2019; Muddashetty et al., 2011; Stefanovic et al., 2015a). Upon mGluR signaling and
dephosphorylation of FMRP, AGO2 is released and PSD-95 mRNA is subsequently
expressed (Muddashetty et al., 2011). Interestingly, immunoprecipitation studies have
revealed that phosphorylated FMRP also associates with a greater amount of RNAs
approximately 80-nucleotides in length, possibly corresponding to pre-miRNAs, than its
unphosphorylated form (Cheever & Ceman, 2009). Moreover, the same study
demonstrated that unphosphorylated FMRP is unable to interact with Dicer, whereas
deletion of residues 496-503, where primary and secondary phosphorylation events occur,
enables these interactions (Cheever & Ceman, 2009). Given this finding, it has been
proposed that the state of FMRP phosphorylation regulates mRNA translation indirectly
via its interactions with pre-miRNAs and various components of the miRNA biogenesis
pathway.
In this study, we sought to investigate FMRP ISO1 interactions with pre-miRNAs,
including those that contain G-rich regions with the potential to form GQ structures, and
how miRNA maturation is subsequently affected. Moreover, given that FMRP
phosphorylation has been shown to potentially regulate binding to pre-miRNAs, we wanted
to investigate how the FMRP ISO1 phosphomimic, FMRP ISO1 (S500D), alters these
interactions and the production of mature miRNAs. We hypothesized that FMRP plays a
role in the pre-miRNA maturation and that primary phosphorylation of FMRP will affect
its function with respect to miRNA biogenesis and translation regulation.
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Chapter 3.2 Pre-miRNA-125a Folds into an Extended Stem Loop Structure. Given
the previously established involvement of FMRP in miRNA-125a – AGO2 recruitment to
PSD-95 mRNA for translation repression purposes, as well as the potential oncogenic roles
of mature miRNA-125a, we chose to investigate its precursor miRNA (pre-miRNA-125a,
Table 3.1) for this study (Jiang et al., 2010; Kim et al., 2012; Muddashetty et al., 2011).
Due to its multiple guanine tracts (numbered 1-7 in Figure 3.2A) we analyzed the sequence
using the online QGRS Mapper software, which predicted that a two-plane GQ structure
can potentially form within pre-miRNA-125a using G-tracts 4, 5, 6, and 7 (Kikin et al.,
2006). As the formation of GQ structures within pre-miRNAs has been proposed to
interfere with proper miRNA processing, we first investigated whether the predicted GQ
structure forms within the context of the full-length pre-miRNA-125a sequence
(Arachchilage et al., 2015; Pandey et al., 2015).
pre-miRNA125a

5’ GGUGCCAGUCUCUAGGUCCCUGAGACCCUUUAACCUGUGAGGACA
UCCAGGGUCACAGGUGAGGUUCUUGGGAGCCUGGCGUCUGGCC 3’

miRNA-125a-5p

5’ UCCCUGAGACCCUUUAACCUGUGA 3’

Table 3.1: Pre-miRNA-125a and mature miRNA-125a sequences. Guanine-rich regions with the potential to
form GQ structures are underlined and bolded.
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Figure 3.2: Biophysical characterization of pre-miRNA-125a. Predicted secondary structures of premiRNA-125a (A) with G-tracts proposed to be involved in GQ formation (numbered 1-7) highlighted in red
and boxed. Representative structure was created using RNAstructure prediction software (Reuter &
Mathews, 2013). 1H NMR spectroscopy (B) revealed imino proton resonances corresponding only to stem
loop formation, similar to the results from CD spectroscopy experiments (C), indicating no GQ structure
forms within pre-miRNA-125a.

The full-length pre-miRNA-125a sequence was first characterized using 1D 1H
NMR spectroscopy, focusing on the imino proton resonances from 10 to 15 ppm (Figure
3.2B). As K+ ions are known to stabilize GQ structures, increasing concentrations of KCl
were titrated into the sample in the range of 0-150 mM (Williamson et al., 1989). At all
concentrations of KCl investigated, multiple resonances were observed in the region of 12
to 14.5 ppm, indicative of Watson-Crick base pairing in a stem loop structure (Fürtig et al.,
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2003). Interestingly, the broad imino proton resonances typically corresponding to
Hoogsteen base pairing in GQ structures are absent at all investigated concentrations of
KCl, including when the sample is annealed in the presence of 150 mM KCl, indicating
that the structure does not form in the context of the full-length pre-miRNA (Figure 3.2B).
The lack of GQ formation is likely due to lower stability involved with two-plane
structures, resulting in less π-π stacking interactions, as well as larger loop-lengths between
successive G-tracts, collectively containing 15-nucleotides, which inversely affects overall
stability (Guédin et al., 2010; Zhang et al., 2011). Non-GQ imino proton resonances were,
however, also observed in the 10 to 12 ppm region. These resonances can be assigned to
the five GU wobble base pairs predicted to form within the secondary structure for premiRNA-125a, as well as to the imino proton of guanine residues engaged in GC base pairs
immediate to an internal loop, multiple of which have also been predicted to form (Figure
3.2A) (Glemarec et al., 1996).
CD spectroscopy experiments confirmed that a GQ structure does not form in premiRNA-125a (Figure 3.2C). Similar to the 1H NMR spectroscopy experiments, KCl was
titrated into the sample at increasing concentrations from 1-150 mM in order to stabilize
any GQ structures formed. At all KCl concentrations investigated, an intense negative band
at 210 nm and positive band at 265 nm were observed, with small negative bands apparent
at ~235 nm and ~295 nm (Figure 3.2C). The observed bands are consistent with the
formation of a helical A-RNA structure, which gives rise to a positive band at 260 nm, a
negative band at 210 nm, and a small negative band between 290-300 nm (Ranjbar & Gill,
2009). Moreover, the intensity of the bands at 210 nm and 265 nm slightly increased in
intensity upon increasing KCl titration, indicating stabilization of the stem loop structure.
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Taken together, these results confirm the 1H NMR analysis that pre-miRNA-125a solely
adopts a stem loop conformation, with the predicted two-plane GQ not forming in the
context of the full-length sequence.
The formation of a pre-miRNA stem loop structure is essential not only for their
export to the cytoplasm, but also for subsequent recognition and processing by the Dicer
enzyme (Bernstein et al., 2001; Hutvágner et al., 2001; Yi et al., 2003). Interference with
this structure, whether by alternate structure formation or targeting by small molecules,
results in dysregulation of mature miRNA production (Arachchilage et al., 2015; Pandey
et al., 2015; Young et al., 2010). As our characterization has confirmed that full-length premiRNA-125a folds solely into the stem loop structure necessary for its biogenesis, we next
investigated this process and the involvement of FMRP.

Chapter 3.3 FMRP ISO1 (S500D) Increases the Processing of Pre-miRNA-125a. To
monitor the enzymatic cleavage of pre-miRNA-125a into mature miRNA-125a, the
protocol for a previously established Dicer cleavage assay was adapted (Pandey et al.,
2015). Briefly, samples of 150 nM pre-miRNA-125a were prepared in a buffer consisting
of 10 mM Tris (pH 7.4), 1 mM MgCl2, and 0.15 mM ATP, followed by incubation at 37
°C in the presence of Dicer enzyme (0.5 units) and various FMRP isoforms for 16-hours.
Proteinase K was subsequently added to digest Dicer and FMRP isoforms and samples
were electrophoresed on a 15% nondenaturing TBE gel (Figure 3.3A). The results were
striking, in that the full-length pre-miRNA-125a band was absent in lanes 2 and 3, which
corresponded to incubation with FMRP ISO1 and FMRP ISO1 (S500D), respectively.
Moreover, the sample incubated with FMRP isoform 7 (ISO7), which contains the
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truncated KH2 variable loop, resulted in a fainter band corresponding to full-length premiRNA-125a (lane 5) as compared to the control lane (lane 6). It should be noted that
expression and purification of the FMRP ISO1 triple phosphomimic (ISO1 3P), containing
S497D, S500D, and S504D mutations, has not yet been optimized and results are
inconclusive (Figure 3.3A and 3.3B, lane 4). Based on these results, we hypothesized that
the disappearance of full-length pre-miRNA-125a bands in both FMRP ISO1 and ISO1
(S500D) lanes corresponded to cleavage of the pre-miRNA by Dicer in the presence of
these particular isoforms. During optimization of the Dicer cleavage assay procedure, we
repeated this experiment with incubation time of the samples decreased from 16-hours to
2-hours (Figure 3.3B). Surprisingly, the band corresponding to full-length pre-miRNA125a is now evident in the samples incubated with Dicer and FMRP ISO1 (lane 2), whereas
that in the presence of Dicer and FMRP ISO1 (S500D) (lane 3) remains absent. Moreover,
the full-length pre-miRNA-125a band in lane 5, in which the RNA was incubated in the
presence of Dicer and FMRP ISO7, is of similar intensity to the control lane (lane 6). It is
likely that any cleavage products produced in these experiments were below the detection
limit of the dye used to stain the gels, as initial samples were prepared to an RNA
concentration of only 150 nM. These results indicate that the enzymatic cleavage of premiRNA-125a by Dicer in the presence of various FMRP isoforms is time-dependent, with
samples incubated in the presence of FMRP ISO1 (S500D) being cleaved in under 2-hours,
whereas those in the presence of FMRP ISO1 require longer incubation.
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Figure 3.3: Effect of FMRP isoforms on Dicer-mediated cleavage. Samples of pre-miRNA-125a (150 nM)
were incubated at 37 °C in the presence of Dicer and various FMRP isoforms for 16-hours (A) and 2-hours
(B), followed by digestion of proteins and electrophoresing in a 15% nondenaturing polyacrylamide gel.
Results from incubation in the presence of ISO1 (3P), which contained S497D, S500D, and S504D mutations,
were inconclusive. Full-length pre-miRNA-125a (88-nucleotdies, lane 6) and mature miRNA-125a-5p (24nucleotides, lane 7) were used as molecular weight markers.

Due to the drastic differences between FMRP ISO1 and FMRP ISO1 (S500D)
following a 2-hour incubation (Figure 3.3B, lanes 2 and 3), we focused on these two
isoforms of the protein in subsequent experiments. In order to monitor the cleavage of premiRNA-125a as a function of time, 1 µM samples were prepared under similar conditions
and aliquots were taken during the 70-minute incubation in 10-minute intervals, after which
proteinase K was added to digest Dicer and FMRP isoforms. Samples were subsequently
run on 20% denaturing polyacrylamide TBE gels, which included full-length pre-miRNA125a (88-nucleotides) and mature miRNA-125a-5p (24-nucleotides) controls. The band
corresponding to full-length pre-miRNA-125a incubated in the presence of Dicer and
FMRP ISO1 decreases slightly in intensity over time with a concomitant increase in
intensity of intermediate bands (Figure 3.4, left panel). However, incubation of premiRNA-125a with Dicer and FMRP ISO1 (S500D) resulted in increased enzymatic
cleavage, as the full-length pre-miRNA-125a band decreases in intensity after only 10minutes of incubation (Figure 3.4, right panel, lane 3) and is nearly undetectable by 30-
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minutes (Figure 3.4, right panel, lane 5). Additionally, lower molecular weight cleavage
products appear following incubation with the two proteins, with at least two bands clearly
visible in the 70-minute incubation sample (right panel, lane 9) that are similar in molecular
weight to that of the mature miRNA-125a-5p control (right panel, lane 10). It should be
noted that intermediate bands are seen in Figure 3.4, in which the initial RNA
concentration is 1 µM, whereas the initial RNA concentration in Figure 3.3 is 150 nM,
likely resulting in product band intensities below the limit of detection. These results
confirm those seen in Figure 3.3B, in which the cleavage of pre-miRNA-125a by Dicer
and FMRP ISO1 (S500D) occurs at a faster rate than in the presence of Dicer and FMRP
ISO1, although the mechanism by which this occurs is unknown at this time.

Figure 3.4: Time-dependent Dicer cleavage assay of pre-miRNA-125a. Incubation of samples with Dicer
and FMRP ISO1 (left panel) or ISO1 (S500D) (right panel) were performed simultaneously and aliquots
were removed in 10-minute intervals for each, followed by addition of proteinase K to digest Dicer and
FMRP isoforms. Samples were run in parallel in 20% denaturing polyacrylamide gel electrophoresis. Lane
1 (R) corresponds to the full-length pre-miRNA-125a (88-nucleotides) control, lane 2 (R+D) is pre-miRNA125a with Dicer only for 70-minutes, lanes 3-9 are 10-minute interval aliquots of pre-miRNA-125a with
Dicer and FMRP, and lane 10 (M) contains the mature miRNA-125a-5p (24-nucleotides) control.

Interestingly, samples that were incubated in the presence of only Dicer at 37 °C
for 70-minutes exhibited no enzymatic cleavage compared to the full-length pre-miRNA125a control (compare Figure 3.4, both panels, lanes 1 and 2). To better understand this
phenomenon, control experiments were performed in which pre-miRNA-125a was
incubated with 0.5 units of Dicer only and aliquots were taken in 10-minute intervals.
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Similar to the results seen previously, enzymatic activity was not evident in any of the
samples (Figure 3.5). Degradation of pre-miRNA-125a due to long-term storage resulted
in bands below the full-length pre-miRNA band, indicated by an asterisk (*) in Figure 3.5
(lane 1). These results are surprising as Dicer has been clearly identified in the literature as
being the endoribonuclease responsible for the cleavage of pre-miRNAs into their mature
miRNA products within the biogenesis pathway (Bernstein et al., 2001; Hutvágner et al.,
2001). Subsequent experiments in which incubation time was increased, as well as using a
modified ultra-active form of recombinant Dicer, similarly produced no enzymatic
cleavage of pre-miRNA-125a (data not shown).

Figure 3.5: Dicer only cleavage assay control. Samples were prepared and incubated as previously
described, with aliquots removed every 10-minutes. Samples were electrophoresed on a 20% denaturing
polyacrylamide gel. Lane 1 (R) corresponds to the full-length pre-miRNA-125a (88-nucleotides) control, lane
2 (R+D) is pre-miRNA-125a with Dicer only for 70-minutes, and lanes 3-9 are 10-minute interval aliquots
of pre-miRNA-125a with Dicer only. Bands marked with an asterisk (*) denote degradation of pre-miRNA125 due to long-term storage.

The finding that the recombinant Dicer protein was not responsible for enzymatic
cleavage was surprising and further confounded the results seen in Figure 3.4. Thus, we
performed additional control experiments, incubating samples at 37 °C with only the two
FMRP isoforms, to determine how the RNA enzymatic cleavage was affected by just
FMRP ISO1 (S500D) compared to FMRP ISO1 (Figure 3.6). Similar to the results seen in
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Figure 3.4 (left panel), incubation of pre-miRNA-125a with only FMRP ISO1 did not
result in complete cleavage of the pre-miRNA (Figure 3.6, left panel). However, a visible
decrease in intensity of the full-length pre-miRNA-125a band was observed, with bands
corresponding to intermediate cleavage products increasing in intensity upon longer
incubation with the protein. Moreover, incubation of pre-miRNA-125a in the presence of
only FMRP ISO1 (S500D) revealed the formation of intermediate cleavage products, with
almost complete disappearance of all bands after 70-minutes of incubation (Figure 3.6,
right panel). These results were unexpected, as FMRP has been shown to function as an
RNA-binding and RNA-shuttling protein, with no evidence in the literature of FMRP
harboring enzymatic activity.

Figure 3.6: FMRP only cleavage assay control. Samples were prepared as described previously but
incubated only in the presence of FMRP ISO1 (left panel) or FMRP ISO1 (S500D) (right panel). Samples
were electrophoresed on a 20% denaturing polyacrylamide gel. Lanes 1 and 2 (R and R+D) correspond to
the full-length pre-miRNA-125a (88-nucleotides) control, lanes 3-9 are 10-minute interval aliquots of premiRNA-125a with either FMRP ISO1 or FMRP ISO1 (S500D), and lane 10 (M) contains the mature miRNA125a-5p (24-nucleotides) control. Bands marked with an asterisk (*) denote degradation of pre-miRNA-125
due to long-term storage.

We hypothesized that the enzymatic activity observed in Figure 3.6 could be due
to either an unknown intrinsic enzymatic activity of FMRP, which is amplified in the
phosphorylated mimic of the protein, or contamination of the recombinant protein during
expression and purification. To ensure the cleavage was isolated to only incubation with
FMRP isoforms, control experiments were performed in which pre-miRNA-125a was
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incubated in the presence of recombinantly expressed FUS, another RNA-binding protein,
and BSA (Figures 3.7A and 3.7B). The results from these experiments indicated no
enzymatic cleavage of pre-miRNA-125a over the course of 70-minutes, similar to the
results seen in Figure 3.5 with only the Dicer enzyme present during incubation. Lower
molecular weight bands were present in all samples, including the pre-miRNA-125a
control (lane 1), indicating that RNA degradation of the transcribed RNA was occurring.

Figure 3.7: FUS and BSA cleavage assay controls. Pre-miRNA-125a samples were incubated in the presence
of recombinantly expressed FUS (A) or BSA (B) and aliquots were taken in 10-minute intervals. Samples
were electrophoresed on a 20% denaturing polyacrylamide gels. Lane 1 (R) corresponds to the full-length
pre-miRNA-125a (88-nucleotides) control, lane 2 (R+D) is pre-miRNA-125a with Dicer for 70-minutes,
lanes 3-9 are 10-minute interval aliquots of pre-miRNA-125a with Dicer and either FUS or BSA, and lane
10 (M) contains the mature miRNA-125a-5p (24-nucleotides) control.

To determine whether this enzymatic activity occurred only with pre-miRNA-125a,
further control experiments were performed with another guanine-rich pre-miRNA. A
recent study using selective 2’-hydroxyl acylation analyzed by Li2+-based primer extension
(SHALiPE) analysis revealed that pre-miRNA-149 forms a GQ structure with a parallel
topology in the presence of K+ ions (Kwok et al., 2016). Biophysical characterization of
this sequence in our lab produced similar results (data not shown). Given the original
interest of this study to potentially investigate GQ-forming pre-miRNAs and the effect of
FMRP on their Dicer-mediated cleavage, we transcribed pre-miRNA-149 and performed a
similar cleavage analysis (Figure 3.8A). Samples were incubated in the presence of FMRP
ISO1 or FMRP ISO1 (S500D) at 37 °C for 50-minutes, with aliquots taken in 10-minute
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intervals. Nondenaturing PAGE revealed similar results to those seen with pre-miRNA125a, with FMRP ISO1 having a small effect on pre-miRNA-149 processing (Figure 3.8A,
left panel), while FMRP ISO1 (S500D) resulted in the nearly complete degradation of the
pre-miRNA and all intermediate products (Figure 3.8A, right panel). It should be noted,
however, that the GQ structure within pre-miRNA-149 was shown to form only in the
presence of K+ ions, of which none were introduced in the preparation of these samples,
suggesting the structure is likely folded into a stem loop conformation (Kwok et al., 2016).
To examine whether this enzymatic cleavage effect by FMRP was seen only with
pre-miRNA stem loop structures, or if the activity extended to other RNA structures as
well. Previous work in our lab focused on investigating long-range interactions between
the 3’ and 5’ UTR of the hepatitis C virus (HCV) genome, including a 55-nucleotide stem
loop within the 5’ UTR (Shetty et al., 2013). We performed a control experiment using this
55-nucleotide region of HCV mRNA (henceforth termed HCV for simplicity) to test FMRP
cleavage ability (Figure 3.8B). Similar to previous experiments with pre-miRNA samples,
incubation of HCV with FMRP ISO1 (S500D) resulted in distinct cleavage products,
beginning after only 10 minutes of incubation (Figure 3.8B, right panel, lane 2). Strikingly,
cleavage of the HCV mRNA was also observed upon incubation with FMRP ISO1, though
to a lesser extent (Figure 3.8B, left panel). While this cleavage was apparent for premiRNA-125a as well (Figure 3.6), the band corresponding to the full-length pre-miRNA
never fully disappeared. In contrast, the band corresponding to the full-length 55nucleotide HCV mRNA is completely absent after 70 minutes of incubation with FMRP
ISO1 (Figure 3.8, left panel, lane 6). It is unclear at this time why there is a discrepancy in
enzymatic activity of FMRP ISO1 with HCV RNA compared to pre-miRNA-125a and pre-
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miRNA-149. One possibility is that the differences in secondary structures between the
RNAs results in altered accessibility for enzymatic cleavage, however, further studies are
necessary.

Figure 3.8: Pre-miRNA and mRNA cleavage assay controls. The 90-nucleotide pre-miRNA-149 (A) and a
55-nucletide portion of the HCV 5’ UTR (B) were incubated with FMRP ISO1 and FMRP ISO1 (S500D) for
50 and 70 minutes, respectively, with aliquots taken every 10-20 minutes. Samples were electrophoresed on
20% denaturing polyacrylamide gels. For (A), lane 1 (R) corresponds to the full-length pre-miRNA-149
control, lane 2 (R+D) is pre-miRNA-149 with Dicer for 50-minutes, lanes 3-7 are 10-minute interval aliquots
of pre-miRNA-149 with Dicer and either FMRP ISO1 or ISO1 (S500D), and lane 8 (M) contains the mature
miRNA-125a-5p (24-nucleotides) control. For (B), lane 1 (R) corresponds to the full-length HCV RNA
control, lanes 2-5 are 10- to 20-minute interval aliquots of HCV with either FMRP ISO1 or ISO1 (S500D),
and lane 6 (M) contains the mature miRNA-125a-5p (24-nucleotides) control.

The reaction buffer adapted from Pandey et al. included 0.15 mM ATP and 1 mM
MgCl2, both of which are required for Dicer enzymatic activity. To determine whether
these components were necessary for the enzymatic activity exhibited in the presence of
only FMRP ISO1 or FMRP ISO1 (S500D) (Figures 3.9A and 3.9B, respectively), control
experiments were performed in the absence of each. In the presence of ISO1, the absence
of Mg2+ ions did not appear to have a significant effect on the cleavage of pre-miRNA125a (Figures 3.9A and 3.9B, top panels), as both exhibited minimal change in intensity
of the full-length pre-miRNA-125a band. Similarly, incubation of pre-miRNA-125a in the
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presence of FMRP ISO1 (S500D) without ATP (Figure 3.9A, bottom panel) or without
MgCl2 (Figure 3.9B, bottom panel) indicated similar enzymatic activity, as the full-length
pre-miRNA-125a band decreases in intensity with longer incubation time. However, it
should be noted that while intermediate bands also decreased in intensity over time (Figure
3.6, right panel), their intensity appeared to stay relatively consistent after 30 minutes of
incubation in the absence of both components (Figures 3.9A and 3.9B, bottom panels, lane
4). These results appear to suggest that the enzymatic activity observed is not dependent
on either MgCl2 or ATP. Preliminary studies investigating the effect of adding excess
EDTA to chelate Mg2+ ions bound during the purification process showed decreased premiRNA-125a cleavage in the presence of FMRP ISO1 (S500D) (data not shown). The
presence of these ions may stabilize pre-miRNA-125a stem loop structures, preventing
complete processing and resulting in prolonged intermediate structures, though further
studies are required to confirm these findings.
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Figure 3.9: Buffer component and temperature cleavage assay controls. Pre-miRNA-125a cleavage in the
absence of 0.15 mM ATP (A), 1 mM MgCl2 (B), and at 25 °C (C) was examined. Samples were incubated in
the presence of FMRP ISO1 (top panels) or FMRP ISO1 (S500D) (bottom panels) for 70 minutes and
electrophoresed on 20% denaturing polyacrylamide gels. Lane 1 (R) corresponds to the full-length premiRNA-125a (88-nucleotides) control, lanes 2-8 are 10-minute interval aliquots of pre-miRNA-125a with
either FMRP ISO1 or FMRP ISO1 (S500D, and lane 10 (M) contains the mature miRNA-125a-5p (24nucleotides) control.

To examine the effect of temperature on the enzymatic cleavage of pre-miRNA125a in the presence of each FMRP isoform, we performed control experiments with the
incubation temperature lowered from 37 °C to 25 °C (Figure 3.9C). As seen in Figure
3.9C (top panel), incubation of pre-miRNA-125a with FMRP ISO1 does not seem to effect
cleavage, with results similar to those seen previously at 37 °C (Figure 3.6, left panel).
However, decreased enzymatic activity is observed for pre-miRNA-125a incubated in the
presence of FMRP ISO1 (S500D) at 25 °C (Figure 3.9C, bottom panel). While band
intensity of cleavage products increases over time, the concomitant disappearance of the
full-length pre-miRNA-125a band does not occur. Moreover, as with the control
experiments performed in the absence of ATP and MgCl2 (Figures 3.9A and 3.9B, bottom
panels), intermediate band intensity does not appear to change with longer incubation.
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Taken together, these results suggest that enzymatic activity occurs for both premiRNA and other RNA sequences in the presence of FMRP ISO1, with the activity
increased in the presence of its phosphomimic isoform (S500D). Multiple batches of FMRP
ISO1 and FMRP ISO1 (S500D) were expressed and purified and experiments were
repeated, with the results remaining consistent each time (data not shown). This suggested
that the observed enzymatic activity was not due to a one-time contamination, however,
consistent purification errors could be not ruled out. One possibility is that a protein with
enzymatic activity is binding to and co-purifying with FMRP. To investigate this, a purified
and concentrated stock of FMRP ISO1 (S500D) was analyzed by SDS-PAGE (Figure
3.10A, left panel). A distinct band corresponding to FMRP (~71 kDa) was observed, with
three lower bands (Top, Middle, Bottom) also apparent. All four bands were excised and
subjected to in-gel proteolytic digest as described in Materials and Methods. Resulting
digested protein samples were analyzed by bottom-up mass spectrometry (MS) and
compared against the Swiss Protein Data Bank to determine the identity of each band,
confirming the identity of the top band as FMRP (Figure 3.10A, right panel). Interestingly,
the Middle band, which was the most intense of the “impurity” bands, was also identified
to be FMRP. This truncation is likely the result of premature translation termination during
FMRP expression, as the corresponding band is present immediately following protein
purification (data not shown), and thus not a result of protein degradation from long-term
storage. Furthermore, the Top band was identified by MS as type II keratin, a fibrous
structural protein found in hair, nails, and dust. However, this ubiquitous contamination is
likely not the source of the enzymatic activity in the cleavage assays. Unfortunately, the
identity of the Bottom band could not be identified due to its low abundance.
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Figure 3.10: Mass spectrometry analysis of FMRP (S500D). SDS-PAGE analysis (A) of FMRP (S500D)
revealed a band corresponding to FMRP, as well as three potential contaminants (Top, Middle, Bottom).
Results from in-gel proteolytic cleavage followed by MS analysis are shown with approximate molecular
weights for the Middle and Bottom bands determined from their migration distances. Amino acid coverage
of FMRP ISO1 (S500D) in-solution proteolytic cleavage followed by MS analysis is shown in (B).

To confirm these results, in-solution proteolytic digest and MS analysis was
performed on the purified and concentrated FMRP ISO1 (S500D) stock (Figure 3.10B).
Comparing the resulting peptide fragments to the sequence of FMRP revealed 33% amino
acid coverage, confirming the identity of the protein in solution. Further searches of the
resulting peptide fragments from this digest against the entire Swiss Protein Data Bank
revealed FMRP as having the highest amino acid coverage (data not shown). Based on
these studies, there is no strong evidence that the recombinantly expressed FMRP ISO1
(S500D) contains any contaminants that would contribute to the enzymatic activity
observed for pre-miRNA-125a and other control RNAs.
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Chapter 3.4 Discussion. The results of this study are preliminary, and no definitive
conclusions can be drawn at this time. Future directions of this study will first focus on
optimizing the cleavage assay in the presence of only the Dicer enzyme, as multiple studies
have demonstrated the cleavage of pre-miRNAs using this technique (Kim et al., 2005;
Pandey et al., 2015; Provost et al., 2002). Future work may also include expressing and
purifying the recombinant human Dicer enzyme in Spodoptera frugiperda (Sf9) insect
cells, which was attempted in this study but ultimately unsuccessful (data not shown) (De
& Macrae, 2011; Ye & Liu, 2008). This would potentially circumvent any problems arising
from recombinant Dicer protein stocks purchased from chemical retailers. Furthermore,
attempts were made to determine the exact molecular weight of the cleavage products insolution by MS, but resulting data were inconclusive. Using established protocols for the
identification of small oligonucleotides by MS, the identity of these products could be
determined which would allow for a better understanding of the mechanism of enzymatic
processing (Shah & Friedman, 2008). Finally, mutations will be made to the FMRP ISO1
(S500D) protein to determine where the enzymatic activity could potentially arise.
Preliminary sequence alignment studies were performed against a variety of known
enzymes, such as AGO2, Dicer, and various RNases, yielding inconclusive results (data
not shown). An initial step in this process will be to focus on the FMRP isoforms spliced
during FMR1 mRNA maturation which lack the KH2 variable loop, including the highly
expressed isoform 7 (Figure 3.1) (Brackett et al., 2013). Initial studies focusing on the
various FMRP isoforms revealed that ISO7 may contain similar enzymatic function, as
evidenced by the decreased full-length pre-miRNA-125a band intensity in Figure 3.2A,
but further investigation is necessary. Mutations will also focus on the truncation of FMRP
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to exclude the entire KH2 domain, as well as the other KH domains of the protein (KH0
and KH1, Figure 3.1), which will elucidate regions of the protein required for RNA
recognition and processing.
Taken together, the results of this study are interesting and warrant further
investigation into a potentially novel enzymatic function of FMRP. Throughout the three
decades of research focused on FMRP and its roles in FXS, the vast majority of studies
have focused on its functions as an RNA-binding protein involved in mRNA translational
regulation and nucleocytoplasmic shuttling (Bardoni et al., 1999; Darnell et al., 2001; Feng
et al., 1997; Melko & Bardoni, 2010). To date, no studies have proposed enzymatic activity
by the protein, making the findings of this study extremely unique. Furthermore, the
implication that phosphorylation of FMRP could potentially affect this novel function is
intriguing. The state of phosphorylation has previously been implicated in translational
regulation and association with components of the microRNA biogenesis pathway
(Cheever & Ceman, 2009; Muddashetty et al., 2011). Moreover, phosphorylated FMRP
has been shown to interact with RNA molecules approximately 80-nucleotides in length,
corresponding to the size of pre-miRNAs, as well as with mature miRNAs, whereas its
unphosphorylated form does not (Cheever & Ceman, 2009; DeMarco et al., 2019). Thus,
we hypothesize that our results further implicate the state of FMRP phosphorylation in the
mechanistic role of pre-miRNA processing into mature miRNA products, indirectly
affecting mRNA translation.
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Chapter 4: FUS Recognizes GQ Structures Within Neuronal mRNAs
Chapter 4.1 Introduction. The heterogeneous nuclear ribonuclear proteins P2,
commonly referred to as the fused in sarcoma (FUS) protein, belongs to the FET family of
proteins, which also includes Ewing’s sarcoma protein (EWS) and TATA-binding protein
associated factor 15 (TAF15). Members of this family of proteins confer nucleic acidbinding properties, with each containing an RNA-recognition motif (RRM), one or more
RGG regions, and a Cys2/Cys2 zinc finger motif (Iko et al., 2004; Tan & Manley, 2009).
FUS in particular contains three RGG regions, in addition to a low-complexity (LC) prionlike S, Y, Q, G-rich domain and nuclear localization signal (NLS) (Figure 4.1). As with
all members of the FET family, FUS is predominantly localized to the nucleus in nearly all
examined tissues, though cytoplasmic expression has also been observed (Andersson et al.,
2008; Morohoshi et al., 1996; Zinszner et al., 1994). FUS is imported into the nucleus via
the protein Transportin, an interaction mediated by the cooperative methylation of its Cterminal RGG domain (RGG3) (Dormann et al., 2012; Lee et al., 2006).
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Figure 4.1: Schematic representation of FUS and neuronal mRNA GQs. FUS contains a low-complexity S,
Y, Q, G-rich region, RNA recognition motif, Cys2/Cys2 zinc finger motif, nuclear localization signal, and
three RGG domains (A). Predicted Shank1a GQ and PSD-95 GQ2 structures are shown with C to U
mutations indicated by arrows and dashed circles (B) Location of 2-AP substitutions for steady-state
fluorescence experiments are denoted by solid circles.

Among its proposed molecular functions, FUS is believed to play roles in mRNA
processing, transcription, and nucleocytoplasmic shuttling (Åman et al., 1996; Calvio et
al., 1995; Lagier-Tourenne et al., 2010; Law et al., 2006; Tan & Manley, 2009; Zinszner
et al., 1997). When not localized to the nucleus, FUS has been observed within the postsynaptic density (PSD) of rodent hippocampus cells during the early stages of synapse
development, as well as accumulated at the synapse of induced pluripotent human stem
cells (Aoki et al., 2012; Deshpande et al., 2019; Schoen et al., 2016). Furthermore,
overexpression of FUS or mutations within the protein were associated with increased
susceptibility to defects in mouse synapses (Sephton et al., 2014). Taken together, these
studies strongly implicate an additional role of FUS in maintaining synaptic plasticity.
Interestingly, activation of mGluR subtype 5 resulted in translocation of FUS to the
dendrite of mouse hippocampal neurons (Fujii et al., 2005). Given the abnormal spine
densities and morphologies observed in FUS knockdown mice, these results implicate a
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further role of FUS as a synaptic RNA-binding protein responsible for mRNA transport
and regulator of translation at the dendrite (Aoki et al., 2012; Fujii et al., 2005; LiuYesucevitz et al., 2011; Sephton et al., 2014).
Increasing evidence suggests that mRNA can be stored within RNA granules under
adverse growth conditions, and these molecules can be transported to or near the dendrite
upon synaptic input to be locally translated (Anderson & Kedersha, 2009; Knowles et al.,
1996; Mahowald, 1962). Moreover, FUS and other LC domain-containing proteins have
the ability to phase separate in a concentration-dependent manner, trapping RNAs in
protective ribonucleoprotein complexes (Anderson & Kedersha, 2009). Characterization
of cell-free hydrogel droplet formation, mimicking RNA granules, revealed amyloid-like
fibers polymerized together by their LC prion-like domains (Kato et al., 2012). Incubation
of these hydrogel droplets with mouse brain cell lysates revealed not only homo- and
heterotypic trapping of LC domain-containing proteins, but also the sequestration of 11
mRNAs typically transported to dendrites via neuronal granules (Han et al., 2012; Kato et
al., 2012). Interestingly, of the 11 trapped mRNAs enriched, 7 contained G-rich regions
which harbor the ability to form GQ secondary structures (Biffi et al., 2014; Stefanovic et
al., 2015a; Subramanian et al., 2011; Zhang et al., 2014). Furthermore, of the over 5,500
proposed RNA targets of FUS, previous studies have demonstrated the ability of the protein
to target GQ-forming human telomere DNA and telomeric repeat-containing RNA
(TERRA) GQ structures in vitro via its RGG3 domain (Lagier-Tourenne et al., 2012;
Takahama et al., 2013).
Mutations in FUS have been associated with both familial and sporadic cases of
amyotrophic lateral sclerosis (ALS), with a subset of these mutations occurring within the
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RGG3 domain of the protein (Bosco et al., 2010; DeJesus-Hernandez et al., 2010;
Kwiatkowski et al., 2009; Lai et al., 2011; Vance et al., 2009). Given the regulatory role of
FUS at the synapse and its ability to bind telomeric RNA GQ structures via its RGG3
domain, we hypothesized that FUS could also recognize similar structures within the 3’
UTR of some of its neuronal mRNA targets. To test this hypothesis, we investigated two
neuronal mRNAs found enriched in the aforementioned hydrogel droplet studies – Shank1
and PSD-95 – which our lab has previously characterized to contain multiple GQ structures
in their respective 3’ UTRs (Figure 4.1) (Stefanovic et al., 2015a; Zhang et al., 2014).
Shank1 mRNA encodes for a vital component of the PSD, essential for spine density and
morphology, and was identified as a transcript targeted by FUS (Boeckers et al., 2002;
Nakaya et al., 2013). Similarly, PSD-95 encodes for a scaffold protein in the PSD, whose
levels have been shown to be reduced in synaptoneurosomes upon FUS depletion in mice
(Keith & El-Husseini, 2008; Udagawa et al., 2015). Interestingly, both Shank1 and PSD95 mRNAs are also targeted by FMRP via its RGG domain (Stefanovic et al., 2015a; Zhang
et al., 2014). Moreover, FMRP responds to mGluR activation and regulates local
translation at the synapse, potentially implicating similar functions between FUS and
FMRP in mRNA shuttling (Darnell & Klann, 2013; Sephton et al., 2014).
In this study, we found GQ structures within the 3’ UTR of both Shank1 and PSD95 neuronal mRNAs are per se sufficient for recognition by FUS. Furthermore, we
determined that truncation of the FUS RGG3 domain in the ALS-linked R495X mutant
disrupts this binding, indicating that the domain is primarily responsible for the
interactions. Our results suggest a novel mechanism of FUS binding to neuronal mRNAs
and possible regulation of their transport to synapses for local translation.
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Chapter 4.2 FUS C-Terminal RGG3 Domain Recognizes GQ RNA Sequences.
Characterization of Shank1 and PSD-95 mRNAs demonstrated that each harbors
the ability to form multiple GQ structures within their 3’ UTRs: PSD-95 GQ1, PSD-95
GQ2, Shank1a, and Shank1b (Stefanovic et al., 2015a; Zhang et al., 2014). Binding studies
using nondenaturing PAGE examined each GQ structure interactions with a peptide
composed of the FUS RGG3 domain (amino acids 449-526), as it was the only region
within the protein previously shown to bind GQ structures (Imperatore et al., 2020b;
Takahama et al., 2013). For the four GQ sequences studied, binding to the FUS RGG3
peptide was evident at all RNA:RGG ratios investigated (Imperatore et al., 2020b). Since
PSD-95 GQ1 is dynamic, forming alternate conformations, in this study we focused on
PSD-95 GQ2, which forms a single conformation (Imperatore et al., 2020b; Stefanovic et
al., 2015a). Similarly, from the two GQ structures formed in the Shank1 3’ UTR, we
focused only on Shank1a in this study, as this sequence is conserved in mammals, whereas
Shank1b is not (Imperatore et al., 2020b; Zhang et al., 2014).
Shank1a GQ

GGGG UU GGGG AGGG U GUA GGGG G U GGGG

Shank1a GQ M1

GGGG UU GGGG AGGG C GUA GGGG G C GGGG

Shank1 M2

GCCG UU GCCG AGGG C GUA GCCG G C GCCG

PSD-95 GQ2

GGG A GGG A GGG U GGG

PSD-95 GQ2 M1

GGG A GGG A GGG C GGG

PSD-95 M2

GCG A GCG A GCG C GCG

FUS RGG3 Peptide

NH2-APKPDGPGGGPGGSHMGGNYGDDR RGG RGG YD RGG YRG
RGG D RGG F RGG RGG GD RGG FGPGKMDSRGEHRQDRRERPYCONH2

Table 4.1: Shank1, PSD-95, and FUS RGG3 peptide sequences. Guanines involved in GQ formation are
underlined, locations of 2-AP fluorescent analogue substitutions are highlighted in red, and mutated
nucleotides are highlighted by bold and italicized letters. RGG repeats are shown in bold for the FUS RGG3
peptide.
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The finding that FUS can bind to neuronal mRNA GQ structures is a novel
discovery, as it has previously only been shown to bind telomeric DNA and RNA GQ
structures (Imperatore et al., 2020b; Takahama et al., 2013). However, FUS additionally
targets other secondary structures through its RRM and RGG domains, such as GU-rich
sequences, stem loop structures containing UU or UC as the first base pair in the loop, and
conserved GGUG/NGGU motifs (Hoell et al., 2011; Iko et al., 2004; Lerga et al., 2001;
Loughlin et al., 2019). Neither Shank1a GQ nor PSD-95 GQ2 mRNAs were demonstrated
to form stem loop structures when characterized previously, however, both contain at least
one GGUG motif within their sequence (Figure 4.1B and Table 4.1) (Stefanovic et al.,
2015a; Zhang et al., 2014). To determine if the GQ structure within the neuronal mRNAs
is per se sufficient for recognition by FUS, the GGUG stretches were mutated to GGCG in
both Shank1a GQ and PSD-95 GQ2, creating Shank1a GQ M1 and PSD-95 GQ2 M1
mutants, in which GQ structures formation was not impacted (arrows and dashed circles in
Figure 4.1B and Table 4.1). Additionally, two other mutants (named Shank1 M2 and
PSD-95 M2) were synthesized in which GGUG stretches were mutated to GGCG and the
GQ structures were disrupted by replacing guanine residues in the G-tracts with cytosine
residues (Table 4.1).
To determine if the GQ structure is indeed preserved in the Shank1a GQ M1
mutant, 1H NMR spectroscopy experiments were performed, focusing on the imino proton
region between 10 and 12 ppm (Fürtig et al., 2003). In the presence and absence of 150
mM KCl, a known GQ-stabilizer, broad imino proton resonances were observed centered
around 11 ppm, corresponding to Hoogsteen base pairing in GQ structures (Figure 4.2A)
(Williamson et al., 1989). As the Shank1a GQ wild-type sequence folds into a parallel GQ
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structure, CD spectroscopy experiments were performed at 0, 50, and 150 mM KCl to
determine if the conformation is retained in the M1 mutant. At all concentrations of KCl
examined, a positive band at 265 nm and negative band at 240 nm is observed, indicative
of a parallel fold (Figure 4.2B) (Dapić et al., 2003; Miyoshi et al., 2003). Upon addition
of KCl, the positive band at 265 nm increased in intensity, indicating stabilization of the
GQ structure by K+ ions. UV thermal denaturation experiments were subsequently
performed to determine how the GGCG mutation affected stability of the GQ structure,
compared to wild-type Shank1a GQ. Monitoring absorbance at 295 nm, a wavelength
sensitive to GQ dissociation, 10 µM Shank1a GQ M1 was denatured in 10 mM cacodylic
acid, pH 6.5, in the presence of 2.5 mM KCl (Figure 4.2C) (Mergny et al., 1998). The
hypochromic transition corresponding to GQ dissociation was fit using Equations (1) and
(3) (Materials and Methods) to determine a Tm of ~73 °C, similar to that found for the wildtype Shank1a GQ sequence (Zhang et al., 2014). Characterization of the PSD-95 GQ2 M1
sequence also demonstrated retention of a parallel-folded GQ structure with similar
stability to that of its wild-type sequence (Imperatore et al., 2020b; Stefanovic et al.,
2015a).
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Figure 4.2: Characterization of the Shank1a GQ M1 mutant sequence. 1H NMR spectroscopy in the presence
and absence of 150 mM KCl (A) was performed, focusing on the imino proton region between 10-15 ppm.
CD spectra was performed in the presence of 0, 50, and 150 mM KCl (B). Shank1a GQ M1 was denatured
in the presence of 2.5 mM KCl in 10 mM cacodylic acid, pH 6.5 (C) and GQ dissociation was fit using
Equation (1). Nondenaturing PAGE was performed to test binding to the FUS RGG3 peptide (D).

Nondenaturing PAGE was used to test binding of the FUS RGG3 peptide to the
mutant RNA sequence. As seen in Figure 4.2D, Shank1a GQ M1 RNA, which lacks the
GGUG recognition motif but retains the GQ structure, is bound by the FUS RGG3 peptide,
as the free RNA band (lane 1) diminishes upon incubation with increasing concentration
of the peptide, comparable to that seen with the wild-type Shank1a GQ sequence
(Imperatore et al., 2020b). Similar results are seen with the PSD-95 GQ2 M1 sequence,
implying the GQ structure, not the conserved GGUG motif, is responsible for recognition
by the FUS RGG3 domain (Imperatore et al., 2020b).
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Mutations disrupting the ability of Shank1a GQ and PSD-95 GQ2 to form GQ
structures were additionally characterized to determine if the GQ structures within the
neuronal mRNAs are per se sufficient for FUS RGG3 binding. 1H NMR spectroscopy
experiments were performed for both Shank1 M2 and PSD-95 M2 in the presence and
absence of 150 mM KCl, revealing imino proton resonances in the region 12-14.5 ppm,
which corresponds to Watson-Crick base pairs (Figures 4.3A and 4.3B). Additionally,
sharp resonances in the 10-12 ppm region were observed at both 0 and 150 mM KCl. While
the presence of broader resonances in the 10-12 ppm region is indicative of GQ structure
formation, sharp resonances in the same region have also been observed in structures that
do not form such structures, being assigned to imino protons engaged in GU wobble base
pairs or noncanonical GG or GA base pairs (Bhattacharya et al., 2002; Nonin-Lecomte et
al., 2001). Shank1 M2 and PSD-95 M2 sequences cannot form GQ structures because they
lack necessary G-tracts (Table 4.1), however, when folded bimolecularly with the
RNAstructure prediction software, they are predicted to have Watson-Crick base pairs, GU
base pairs, and the potential for GG or GA base pairs (data not shown) (Reuter &
Mathews, 2013).
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Figure 4.3: 1H NMR spectroscopy of Shank1 M2 and PSD-95 M2 sequences. Spectra were acquired in the
absence and presence of 150 mM KCl for both Shank1 M2 (A) and PSD-95 M2 (B) mutants.

To further confirm that the sharp resonances present in the 10–12 ppm region of
the Shank1 M2 and PSD-95 M2 sequences do not originate from GQ structures, whereas
the broad resonances observed in the same region of the Shank1a GQ M1 and PSD-95 GQ2
M1 sequences originate from GQ structures, nondenaturing PAGE was performed in the
presence of 25 mM KCl (Figure 4.4) (Imperatore et al., 2020b). The gels were visualized
first by UV shadowing, where all RNA bands were visible, followed by staining with
NMM, a GQ-specific dye. Both Shank1a GQ M1 and PSD-95 GQ2 M1 RNAs stain in
NMM, indicating GQ formation (Figure 4.4A), whereas neither Shank1 M2 nor PSD-95
M2 sequences stain in NMM, confirming that they do not form GQ structures (Figure
4.4B).
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Figure 4.4: Nondenaturing PAGE of Shank1a GQ and PSD-95 GQ2 mutants. Shank1a GQ M1 and PSD-95
GQ2 M1 mutants lacking the conserved GGUG motif (A) were visualized by UV shadow and stained in the
GQ-specific NMM dye. Shank1 M2 and PSD-95 M2 RNA sequences (B) were visualized similarly.

Nondenaturing PAGE was performed to determine if the neuronal GQ structures
formed within Shank1a GQ and PSD-95 GQ2 are per se sufficient for binding by the FUS
RGG3 domain. Both Shank1 M2 and PSD-95 M2 mutants, which lack the GGUG sequence
and do not form GQ structures, exist in an equilibrium of their monomeric and dimeric
states (lane 1 in Figures 4.5A and 4.5B). Upon the addition of the FUS RGG3 peptide in
increasing ratios, the Shank1 M2 free RNA monomer band decreases slightly in intensity
at higher FUS RGG3 peptide ratios (lanes 3 and 4 in Figure 4.5A), indicating weak
binding. It has been reported previously that FUS has a weakly enriched binding motif
containing G/C nucleotides (Colombrita et al., 2012; Ishigaki et al., 2012). By replacing
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multiple guanine residues with cytosine residues to disrupt the GQ formation, multiple
GCC binding sites were inadvertently created in the Shank1 M2 mutant. Nonetheless, it
should be noted that the free RNA band of the wild-type Shank1a GQ and M1 mutant,
which form GQ structures, disappear at higher FUS RGG3 peptide ratios (Figure 4.2D),
indicating higher affinity for the GQ structures. Taken together, these results indicate that
the GQ structure per se is sufficient for recognition since the Shank1a GQ M1 mutant,
lacking the GGUG recognition sequence but retaining the GQ structure, is bound by the
FUS RGG3 peptide, whereas the M2 mutant lacking both the GGUG sequence and the GQ
structure is bound with low affinity due to the presence of GCC binding sites (Figure
4.5A). Similarly, the PSD-95 M2 mutant is not bound by the FUS RGG3 peptide (Figure
4.5B), whereas the PSD-95 GQ2 M1 mutant was bound by the FUS RGG3 peptide with
higher affinity (Imperatore et al., 2020b).

Figure 4.5: Nondenaturing PAGE of Shank1 M2 and PSD-95 M2 mutants with the FUS RGG3 peptide. Both
Shank1 M2 (A) and PSD-95 M2 (B) mutants were annealed prior to incubation with increasing ratios of the
FUS RGG3 peptide (1:0 to 1:3) for 15-minutes.

Chapter 4.3 FUS Interactions with Neuronal mRNA GQ Structures are Disrupted
by an ALS-Linked Mutation. To quantitatively analyze the binding interactions between
the neuronal GQ structures in Shank1 and PSD-95 mRNAs, steady-state fluorescence
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spectroscopy was performed with both the FUS RGG3 peptide and full-length wild-type
FUS (Imperatore et al., 2020b). Briefly, adenine residues in the loop regions of GQs formed
by Shank1a GQ and PSD-95 GQ2 were substituted with 2-aminopurine (2-AP) fluorescent
analogues and either RGG3 peptide or full-length FUS was titrated into RNA samples,
monitoring changes in steady-state fluorescence of the 2-AP reporter. Binding curves were
subsequently fit using Equation (4) and dissociation constant (Kd) values were determined.
The Kd value for the Shank1a GQ – FUS RGG3 peptide complex was determined to be
271 ± 21 nM, whereas that for the Shank1a GQ – FUS complex was determined to be 88
± 27 nM (Imperatore et al., 2020b). Similarly, the PSD-95 GQ2 – FUS RGG3 peptide
complex Kd was 92 ± 9 nM, whereas that of the PSD-95 GQ2 – FUS complex had a value
of 28 ± 10 nM (Imperatore et al., 2020b). In both cases, the Kd values for the full-length
FUS protein was lower than that of the isolated FUS RGG3 peptide, indicating tighter
binding, possibly due to other RNA-binding motifs within the protein (Loughlin et al.,
2019). Furthermore, RNA-based affinity pull-down assays were used to investigate if
biotinylated Shank1a GQ and PSD-95 GQ2, as well as their respective M2 mutants, could
pull down endogenous FUS when incubated with mouse E17 brain lysate. Both wild-type
Shank1a GQ and PSD-95 GQ2 RNA sequences pulled down endogenous FUS, whereas
their respective M2 mutants lacking both the conserved GGUG motif and GQ structures
did not, confirming the aforementioned results that the GQ structure is per se sufficient for
recognition (Imperatore et al., 2020b).
In an effort to understand the contribution of the other FUS RNA binding domains
to the binding of Shank1a GQ and PSD-95 GQ2, we additionally analyzed the ALS-linked
FUS R495X mutant, which lacks the last 32 amino acids of the C-terminus past position
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495, resulting in a truncated RGG3 domain (Bosco et al., 2010). The FUS R495X mutant
has been identified in a family with early-onset ALS (mean age 35 ± 16 years) and has
been shown to cause a dramatic increase in cytoplasmic accumulation of FUS compared
with other ALS-linked missense mutants, in addition to an altered association with stress
granules (Baron et al., 2013; Bosco et al., 2010). Full-length FUS R495X was
recombinantly expressed using a plasmid encoding for the GST-FUS R495X fusion protein
and purified using affinity chromatography. Increasing increments of the protein were
titrated into annealed samples of 200 nM PSD-95 GQ2 or Shank1a GQ containing the 2AP fluorescent reporter in 10 mM cacodylic acid, pH 6.5, and 150 mM KCl in the presence
of a 5-fold excess of BSA. We observed a linear increase of the steady-state fluorescence
of the 2-AP reporter in Shank1a GQ (Figure 4.6A), indicating low affinity binding at these
concentrations, whereas no changes were observed in PSD-95 GQ2 (Figure 4.6B). Since
the 2-AP reporter is located in an eight-nucleotide loop containing the GGUG motif within
the GQ structure, it is possible that the changes in fluorescence for Shank1a GQ reflect the
binding of this motif by FUS R495X. Subsequently, as the RGG1, RGG2, and RRM
domains remain intact in FUS R495X and this mutant does not bind Shank1a GQ and PSD95 GQ2 with high affinity as determined for the wild type FUS, we conclude from these
experiments that an intact RGG3 domain is required for the GQ structure recognition
(Imperatore et al., 2020b).
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Figure 4.6: Steady-state fluorescence spectroscopy of Shank1a GQ and PSD-95 GQ2 with the ALS-linked
FUS R495X mutant. Increments of 30 nM FUS R495X were titrated into 200 nM Shank1a GQ (A) and PSD95 GQ2 (B) RNA in the presence of 5-fold excess BSA to screen non-specific binding.

Chapter 4.4 Discussion. In this study, we demonstrated for the first time that GQ
structures within the neuronal mRNAs Shank1 and PSD-95, whose protein products are
vital for synaptic plasticity and maintenance, are per se sufficient for recognition by FUS.
Previous studies have demonstrated similar interactions between neuronal GQ-forming
mRNAs and FMRP, proposed to regulate their translation (Blice-Baum & Mihailescu,
2014; DeMarco et al., 2019; Evans & Mihailescu, 2012; Stefanovic et al., 2015b; Zhang et
al., 2014). The dissociation constant of the FMRP – PSD-95 GQ2 complex was 100 ± 17
nM, whereas that of the FMRP – Shank1a GQ complex was 198 ± 28 nM, both in the nM
range, but higher than those determined for the complexes formed by FUS with these
respective GQ-forming neuronal mRNAs (DeMarco et al., 2019; Imperatore et al., 2020b;
Zhang et al., 2014). Thus, it is feasible that FUS could directly compete with FMRP for
binding these neuronal GQ targets. Since FMRP is a regulator of translation, by displacing
FMRP, FUS could indirectly affect the translation of these mRNAs. However, the FUSFMRP-RNA interactions are more complex, considering that FUS and FMRP interact
directly (Blokhuis et al., 2016; He & Ge, 2017). The FMRP tandem Agenet domain
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(Figure 3.1) is proposed to recognize methylated arginine residues within the FUS RGG
domains, with the deletion of each individual FUS RGG domains resulting in attenuated
interactions with FMRP (He & Ge, 2017). Is has also been shown that FUS mutants lacking
both RGG2 and RGG3 domains or lacking the RRM domain do not interact with FMRP
(Blokhuis et al., 2016). Taken together, these results suggest that the same FUS domains
involved in binding FMRP are also involved in binding some of its RNA targets, and this
hypothesis is further supported by our results that the FUS RGG3 domain, which is
implicated in the FMRP Agenet recognition, also binds the neuronal GQ-forming mRNA
targets.
Several mutations within the FUS RGG3 domain are associated with ALS, and it
has been shown that the FUS R514G and R521G mutants interact similarly with FMRP as
compared with wild-type FUS (He & Ge, 2017). Another ALS associated FUS mutant,
R521C, has comparable interactions with FMRP, however, the FUS R521C mutant
affected the FMRP translation regulator function at the synapse, as the synaptic expression
of MAP1B mRNA, a well-characterized FMRP target, increased significantly when the
cells were transfected with the mutant FUS (Blokhuis et al., 2016; Lu et al., 2004; Menon
et al., 2008). These authors suggested that the FUS R521C mutant increases the synaptic
MAP1B translation by competing for binding to MAP1B mRNA with FMRP, which is a
translational repressor. The data suggesting that wild-type FUS and FMRP bind the same
two neuronal GQ forming RNA targets with comparable dissociation constants are
supportive of such a model (Imperatore et al., 2020b; Stefanovic et al., 2015a; Zhang et al.,
2014). Interestingly, the GQ structure formed within the 5’ UTR of MAP1B mRNA, which
is recognized by FMRP, is also bound by the FUS RGG3 domain (Imperatore et al., 2020b;
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Menon et al., 2008). These results provide additional support of a direct competition
between FMRP and FUS for binding neuronal GQ-forming mRNAs and should motivate
further studies to fully elucidate the role of the FMRP-FUS-neuronal GQ-forming mRNA
interactions in regulating translation. Moreover, given that a number of ALS-associated
FUS mutants are located within its RGG3 domain, their neuronal GQ RNA binding
properties should also be investigated to increase our understanding of the role of FMRP
in the etiology of ALS. Our findings that FUS R495X has impaired binding to Shank1a
GQ and PSD-95 GQ2 mRNAs have implications for a potential FUS loss-of-function at
the synapse with respect to the translation regulation of neuronal mRNA targets containing
GQ structures within their 3’ UTR (Figure 4.7).

Figure 4.7: Proposed mechanism of impaired neuronal mRNA shuttling by the ALS-linked FUS R495X
mutant. Truncation of the FUS RGG3 domain in the R495X mutant results in decreased affinity for GQforming neuronal mRNAs, potentially leading to a loss-of-function at the synapse with respect to translation
regulation.
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Chapter 5: The Highly Conserved s2m Element of SARS-CoV-2 Functions in Genome
Dimerization and Interacts with Host Cellular miRNA-1307-3p
Chapter 5.1 Introduction. A novel coronavirus emerged in late 2019 in Wuhan, Hubei
Province, People’s Republic of China, presenting with pneumonia-like symptoms. As of
November 23, 2020, there have been over 58 million confirmed cases and approximately
1.4 million related deaths globally (Dong et al., 2020). This disease, now termed COVID19, commonly includes characteristics such as fever, cough, myalgia or fatigue, headaches,
and diarrhea (Huang et al., 2020). Patient plasma analysis has also revealed increased
production of cytokines and chemokines, commonly referred to as a “cytokine storm”,
resulting in complications such as acute respiratory distress syndrome (ARDS), and in
severe cases, death (Huang et al., 2020; Mehta et al., 2020). Currently, no approved
prophylactic or therapeutic treatments exist specifically for COVID-19.
The novel coronavirus responsible for COVID-19, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been studied extensively since its genome
was first sequenced (Wang et al., 2020). SARS-CoV-2 belongs to the Nidovirales order,
Coronaviridae family, betacoronavirus genus, lineage B (de Wilde et al., 2018). Viruses
within the Nidovirales order are enveloped, positive-sense, single-stranded RNA viruses
containing large (approximately 30-kilobase) genomes (Fehr & Perlman, 2015; Taiaroa et
al., 2020). Related viruses, such as those that caused the SARS and Middle East respiratory
syndrome (MERS) outbreaks in 2002 and 2012, respectively, share high sequence and
structural similarities to SARS-CoV-2 (Cui et al., 2020; Fehr & Perlman, 2015; Grifoni et
al., 2020).
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Of particular interest are conserved structural elements within the 5’ and 3’ UTRs
of coronaviruses, suggested to be involved in genome replication and circularization,
among other functions (Goebel et al., 2004; Li et al., 2008; Yang & Leibowitz, 2015).
Specifically, stem loops 1 (SL1), 2 (SL2), and 3 (SL3) in the 5’ UTR, as well as the
pseudoknot (PK) stem loop, bulged stem loop (BSL), and hypervariable region (HVR) in
the 3’ UTR, are structurally conserved throughout the family of coronaviruses (Figure 5.1)
(Hsue et al., 2000; Kang et al., 2006; Raman et al., 2003; Raman & Brian, 2005; Züst et
al., 2008).

Figure 5.1: Schematic diagram of coronavirus conserved elements. Specifically, SL1, SL2, and SL3 in the 5’
UTR and the PK, BSL, and HVR in the 3’ UTR are structurally conserved. The s2m element within the HVR
motif is highly conserved among multiple viral families.

Contained within the 3’ UTR HVR is a 41-nucleotide stem-loop II-like motif (s2m)
(Table 5.1), which is highly conserved among not only coronaviruses, but also viruses
within the Astroviridae, Caliciviridae, and Picornaviridae families (Tengs et al., 2013;
Tengs & Jonassen, 2016). Interestingly, this region was recently found to be present within
multiple related insect species as well, though an exact evolutionary link could not be
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established (Tengs et al., 2020). While the specific function of the s2m region remains
unresolved, it has been suggested to play roles in viral replication, hijacking of host protein
synthesis, and RNA interference pathways (Goebel et al., 2004; Robertson et al., 2005;
Tengs et al., 2013). Deletions within the element occurred upon culturing isolates in
permissive cell lines, indicating that the element may confer a selective advantage in
relation to the viral life cycle (Caly et al., 2020). Thus, the unique structural features of the
s2m element and its conservation among various viral families makes it a potentially
attractive target for future therapeutics (Robertson et al., 2005).
SARS-CoV
SARS-CoV
(U5C)
SARS-CoV
(G31U)

5' UUCAUC GAG GCC ACG CGG AGU ACG AUC GAG GGU ACA GUGAA 3'
5' UUCACC GAG GCC ACG CGG AGU ACG AUC GAG GGU ACA GUGAA 3'
5' UUCAUC GAG GCC ACG CGG AGU ACG AUC GAG UGU ACA GUGAA 3'

SARS-CoV-2

5' UUCACC GAG GCC ACG CGG AGU ACG AUC GAG UGU ACA GUGAA 3'

miRNA-1307-3p

5' ACU CGG CGU GGC GUC GGU CGUG 3'

Table 5.1: Sequences of s2m elements and miRNA-1307-3p. Nucleotide differences between SARS-CoV and
SARS-CoV-2 (U5C and G31U) are highlighted in red and underlined.

In this study, we demonstrated the formation of a homodimeric kissing complex
formed through a 4-nucleotide palindrome within the loop region of the s2m element in the
SARS-CoV-2 genome. The kissing dimer intermediate structure is subsequently converted
to a thermodynamically stable extended duplex via chaperone activity of the viral
nucleocapsid (N) protein. Furthermore, we demonstrate that the s2m element of SARSCoV-2 binds to multiple copies of host cellular miRNA-1307-3p, a process mediated by
genome dimerization. Altogether, the results of this study add to the breadth of knowledge
encompassing the coronavirus life cycle and enhance the potential role of the s2m element
as a therapeutic target.
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Chapter 5.2 The s2m Element in the 3’ UTR of SARS-CoV-2 Forms a Homodimeric
Kissing Complex. The SARS-CoV-2 s2m element is proposed to adopt a stem-loop
structure and we noted that within its terminal loop there is a 4-nucleotide palindrome
(GUAC), which we hypothesized could initiate the formation of a homodimeric kissing
complex that could be implicated in genome dimerization (Figure 5.2, top). To investigate
this proposed interaction, nondenaturing gel electrophoresis studies were carried out both
in the presence and absence of Mg2+ ions (Figure 5.3). The SARS-CoV-2 s2m element at
concentrations of 500 nM and 1 µM were prepared in the presence of 1, 5, and 10 mM
MgCl2, conditions which stabilize the kissing dimer conformation, and subsequently split
to be run in parallel in TBE and TBM gels (Marquet et al., 1991; Ohuchi & Nakamura,
2007). As the TBM gels contain 5 mM MgCl2, kissing dimer conformations are retained,
whereas these ions are chelated by EDTA in the TBE gels, resulting in kissing dimer
dissociation (Marquet et al., 1991; Ohuchi & Nakamura, 2007; Shetty et al., 2010). In the
TBM gel we observed three distinct bands at all concentrations of Mg2+ ions investigated
(Figure 5.3A, right), with the lower band (arrow 1) attributed to the monomeric species
and the higher bands (arrows 2 and 3) to two distinct dimeric species. In contrast, upon
chelation of Mg2+ ions by the EDTA in TBE buffer, the two dimeric bands collapse into a
single band, indicating that the motif exists primarily in its monomeric state (Figure 5.3A,
left panel, arrow 1).
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Figure 5.2: Schematic depiction of proposed s2m dimerization mechanism. Kissing complex formation is
mediated by a 4-nucleotide GUAC sequence within the terminal loop region of the motif. The viral N protein
acts as a chaperone in the conversion from the kissing dimer conformation to a thermodynamically stable
extended duplex.

Figure 5.3: Mg2+-dependent nondenaturing TBE and TBM gel electrophoresis of SARS-CoV-2 s2m. Samples
at RNA concentrations of 500 nM and 1 µM were incubated for 1-hour in the presence of 1, 5, and 10 mM
MgCl2. Monomeric conformations are denoted by arrow 1, kissing dimer conformations by arrow 2, and
extended duplex structures by arrow 3. A 100-bp ladder was used as a molecular weight marker.

Bioinformatic analysis of the SARS-CoV-2 genome revealed the s2m element
differs in sequence from that in the SARS coronavirus (SARS-CoV) by only 2-nucleotides
(U5C and G31U, Table 5.1). To determine whether these minor variations in the motif
have an effect on its ability to dimerize, we incubated both SARS-CoV and SARS-CoV-2
s2m elements in the presence of 1 and 10 mM MgCl2 for 1-hour, followed by
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electrophoresing in TBE and TBM nondenaturing gels (Figure 5.4). In the absence of Mg2+
ions, both SARS-CoV and SARS-CoV-2 s2m elements exist primarily in their monomeric
state (Figure 5.4, left panel). Surprisingly, the results from the TBM gel indicated that in
the presence of Mg2+ ions, the equilibrium is shifted drastically towards the dimeric state
for SARS-CoV as compared to that of SARS-CoV-2 (Figure 5.4, right panel).
Additionally, while two dimer bands of lower intensity are present for the SARS-CoV-2
s2m (Figure 5.4, right panel, arrows 2 and 3), only a single dimeric conformation is evident
for SARS-CoV (Figure 5.4, right panel, arrow 2).

Figure 5.4: Mg2+-dependent comparison of SARS-CoV and SARS-CoV-2 s2m elements by nondenaturing
TBE and TBM gel electrophoresis. Both s2m elements at RNA concentrations of 1 µM were incubated with
1 and 10 mM MgCl2 for 1-hour prior to electrophoresing. Monomeric conformations are denoted by arrow
1, kissing dimer conformations by arrow 2, and extended duplex structures by arrow 3.

We hypothesized that one of the dimer bands observed in the SARS-CoV-2 TBM
gel (Figures 5.3 and 5.4, right panels) corresponded to a homodimeric kissing complex,
while the other arose from the spontaneous conversion of the kissing complex to a stable,
extended duplex (Figure 5.2, bottom) during the incubation with MgCl2 and subsequent
4-hour run through the TBM gel. Spontaneous conversion of labile palindromic kissing
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dimers to their extended duplex conformation has been reported for the dimerization
initiation site of other viruses, such as HCV and HIV-1 (Mihailescu & Marino, 2004;
Shetty et al., 2010). The process, which involves strand exchange between two monomers,
is dependent on the intrinsic stability of the monomeric stem-loop structures (Mujeeb et
al., 2007; Rist & Marino, 2002). The conversion of kissing dimer to duplex in the s2m
element was likely hindered by chelation of the ions by EDTA following the 1-hour
incubation with Mg2+ ions, resulting in a band too faint to be detected clearly in the TBE
gel. To test this hypothesis, 1 µM SARS-CoV and SARS-CoV-2 s2m samples were
incubated in the presence of increasing concentrations of MgCl2 at room temperature for
24-hours and subsequently examined by TBE and TBM gel electrophoresis. Both SARSCoV-2 s2m dimer bands are present in the TBM gel (Figure 5.5B, right panel, arrows 2
and 3) with the uppermost dimer band (arrow 3) increasing in intensity at higher MgCl2
concentrations. Similarly, a dimer band which increases in intensity as the MgCl2
concentration increases is clearly apparent in the TBE gel (Figure 5.5B, left panel, arrow
2), indicating that the band corresponds to an extended duplex, which is stable even
following chelation of Mg2+ ions by EDTA. Notably, both dimer bands are more intense
in the TBM gel (compare Figures 5.5A and 5.5B, right panels), with the intensity of the
uppermost dimer band increasing as concentration of MgCl2 in the sample is increased,
indicating stabilization of the kissing complex intermediate followed by conversion to the
duplex conformation during the 24-hour incubation time. Incubation of the SARS-CoV
s2m with 1, 5, and 10 mM MgCl2 for 24-hours at room temperature revealed no upper
dimer band present in the TBE gel (Figure 5.5, left panel), confirming the inability of the
element to spontaneously convert from the kissing dimer to the stable duplex structure.
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These results support the hypothesis that the s2m element in the 3’ UTR of SARS-CoV-2
forms a homodimeric kissing complex stabilized by Mg2+ ions which can spontaneously
rearrange into a stable, extended duplex structure, whereas SARS-CoV s2m is unable to
undergo this conversion. To minimize the spontaneous conversion of the SARS-CoV-2
s2m kissing dimer to duplex conformation, RNA samples were incubated in the presence
of 1 mM MgCl2 for 1-hour in subsequent experiments.

Figure 5.5: Mg2+-dependent nondenaturing PAGE of s2m elements following 24-hour incubation. Samples
were incubated in the presence of 1, 5, and 10 mM MgCl2 followed by incubation for 24-hours at room
temperature. Samples were split and electrophoresed by TBE and TBM PAGE. Both SARS-CoV and SARSCoV-2 undergo degradation during 24-hour incubation (*).

The difference in dimerization properties of the s2m elements is significant,
considering that the SARS-CoV-2 s2m sequence differs from that of SARS-CoV only at
two positions, U5C and G31U (Table 5.1). The nucleotide at position 5 in the s2m element
is variable, however, that in position 31 remains invariant in all viruses in which the
element has been identified (Tengs et al., 2013, 2020; Tengs & Jonassen, 2016). According
to the solved X-ray crystal structure of SARS-CoV s2m, U5 is located in the lower stem
and base-paired to G37, whereas G31 is located in the middle stem, base-paired with C12
(Figure 5.6A) (Robertson et al., 2005). The secondary structure of the SARS-CoV-2 s2m
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element was recently solved by NMR spectroscopy and is conformationally different from
that of SARS-CoV (Wacker et al., 2020). However, it should be noted that while C5
remains base-paired to G37 and retains its position in the lower stem, U31 in SARS-CoV2 s2m is part of a smaller middle stem, forming a base pair with A13 (Figure 5.6B). The
terminal loop region in SARS-CoV s2m is bent into a 90° kink facilitated by a base quartet
interaction, leaving G20 and U21 exposed and possibly orienting them in the right
conformation for kissing dimer formation (Robertson et al., 2005). In contrast, the terminal
loop of SARS-CoV-2 is larger, with the entire GUAC palindrome left exposed. Selective
2’ hydroxyl acylation by primer extension (SHAPE) analysis of the s2m element in SARSCoV-2 confirms the lability of all four nucleotides (Huston et al., 2020; Manfredonia et al.,
2020). Thus, it is likely that the higher flexibility of the entire GUAC loop will result in a
greater entropic penalty upon SARS-CoV-2 s2m kissing dimer formation, potentially
explaining why SARS-CoV s2m more easily forms a kinetically stable kissing complex
structure as compared with SARS-CoV-2, which prefers its monomeric conformation even
in the presence of MgCl2 (Figure 5.3).
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Figure 5.6: Secondary structure characterization of SARS-CoV and SARS-CoV s2m elements. Schematic
representation of SARS-CoV (A) and SARS-CoV-2 (B) s2m element secondary structures were adapted from
experimentally characterized X-ray crystallography and NMR spectroscopy results, respectively (Robertson
et al., 2005; Wacker et al., 2020). Locations of nucleotides differences are highlighted in green (U5C) and
red (G31U). Representations were created using RNAstructure software and edited accordingly (Reuter &
Mathews, 2013). One-dimensional 1H NMR spectroscopy experiments were performed for all four s2m
sequences in the presence of 0 mM MgCl2 (C).

To determine whether the structural differences and altered dimerization properties
of SARS-CoV-2 s2m are due to both nucleotide variations, we investigated two mutated
SARS-CoV sequences in which a single nucleotide mutation was introduced (U5C and
G31U; Table 5.1; compare Figures 5.6A and 5.6B). We employed one-dimensional 1H
NMR spectroscopy to determine if these mutants resemble more the SARS-CoV s2m or
SARS-CoV-2 s2m secondary structures. The SARS-CoV-2 s2m imino proton resonance
region (Figure 5.6C, top spectrum) matched that of its previously determined secondary
structure, allowing us to assign its resonances (Wacker et al., 2020). It should be noted,
however, that our analysis focused on a synthesized 41-nucelotide sequence corresponding
to the SARS-CoV-2 s2m element, whereas previous characterization included two
additional G-C base pairs introduced in the lower stem for transcriptional purposes. In the
SARS-CoV (G31U) s2m spectrum, the imino proton resonances corresponding to U31,
G30, G32, and G28 have similar chemical shifts as compared with the corresponding ones
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in wild-type SARS-CoV-2 s2m (Figure 5.6C). However, those resonances corresponding
to base pairs in the lower stem appear to be broader, potentially due to the fact that in wildtype SARS CoV, the G-C base pair formed by C5-G37 is replaced by the less stable U5G37 (compare Figures 5.6A and 5.6B). As expected, the U31 imino proton resonance is
absent from both wild-type SARS-CoV s2m and SARS-CoV (U5C) s2m mutant, and while
we cannot make unambiguous assignments for these imino proton resonances, the overall
spectra corresponding to wild-type SARS-CoV s2m and its U5C mutant appear to be
similar (Figure 5.6C, bottom two spectra).
Based on the 1H NMR spectroscopy results, we predicted that dimerization of the
SARS-CoV (G31U) s2m mutant will be similar to that of wild-type SARS-CoV-2 s2m,
whereas that of the SARS-CoV (U5C) s2m mutant will resemble that of wild-type SARSCoV s2m. To compare dimerization of the SARS-CoV G31U and U5C mutants to wildtype SARS-CoV and SARS-CoV-2 s2m elements, nondenaturing PAGE was performed,
which indicated similar dimerization properties between wild-type SARS-CoV s2m and
SARS-CoV (U5C) s2m mutant, with both existing primarily in a kissing dimer
conformation in the presence of Mg2+ ions (data not shown). Conversely, wild-type SARSCoV-2 s2m and SARS-CoV (G31U) s2m both exist primarily in their monomeric state
with bands for both kissing dimer and extended duplex present (data not shown). Taken
together, these results indicate that the different nucleotide at position 31, a previously
100% conserved guanine residue in the s2m element of SARS-CoV which is mutated to a
uracil residue in the SARS-CoV-2 s2m, is the single driving force in the drastic difference
in dimerization properties of the motif. Further high resolution 1H,15N sfHMQC NMR
experiments performed on a 900 MHz NMR spectrometer by our collaborators at the
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National Institute of Standards and Technology demonstrated three distinct cross peaks for
U31, indicating that this position is dynamic (data not shown). This lability could be
responsible for the destabilization of the middle stem region of the s2m element in SARSCoV-2, allowing it to more readily convert to the extended duplex conformation as
compared to that of SARS-CoV s2m.

Chapter 5.3 The N Protein of SARS-CoV-2 Converts the s2m Kissing Dimer to a
Stable, Extended Duplex. During the viral life cycle of coronaviruses, the N protein is
primarily responsible for packaging the viral RNA(+) genome into compact
ribonucleoprotein (RNP) complexes during virion assembly (Kang et al., 2020; McBride
et al., 2014). Previous work on HIV-1 and HCV has elucidated additional roles for the
nucleocapsid protein, demonstrating that it acts as a molecular chaperone, converting
kissing complex formations into stable, extended duplexes (Cruceanu et al., 2006; IvanyiNagy et al., 2006; Mihailescu & Marino, 2004; Rein et al., 1998; Shetty et al., 2010). Given
our finding that the s2m element of SARS-CoV and SARS-CoV-2 form homodimeric
kissing complexes, we proposed a similar chaperoning ability by the N protein. To test this
hypothesis, nondenaturing TBE and TBM gel electrophoresis studies were performed to
monitor the formation of a thermodynamically stable duplex (Mihailescu & Marino, 2004;
Shetty et al., 2010).
Both SARS-CoV and SARS-CoV-2 s2m elements were incubated in the presence
of 1 mM MgCl2 to pre-form kissing complex structures, followed by addition of the SARSCoV-2 N protein in a 1:2 ratio and incubation for an additional 30 minutes. To monitor
chaperone activity, proteinase K was subsequently added to the samples to degrade the N
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protein prior to electrophoresing. Upon chelation of Mg2+ ions in the TBE gel, a distinct
dimer band was present in SARS-CoV-2 s2m, indicating the formation of a stable duplex
(Figure 5.7A, left panel, arrow 3). Surprisingly, no distinct dimer band was present in the
SARS-CoV s2m sample incubated with the N protein. In order to ensure the observed effect
was not due to non-specific interactions, control samples were included in which both
RNAs were incubated with 2 µM BSA under similar conditions. In both SARS-CoV and
SARS-CoV-2 s2m samples, the BSA protein had no effect on duplex formation (Figure
5.7A, left panel). An increased intensity of the top dimer band of SARS-CoV-2 s2m after
the action of the N protein (Figure 5.7A, right panel, arrow 3) and concomitant decrease
in the monomer band (Figure 5.7A, right panel, arrow 1) in the TBM gel confirm our
previously established hypothesis that an equilibrium exists between the monomer and two
dimer conformations, with the N protein shifting the equilibrium towards the stable duplex
structure. Additional time-dependent studies monitoring the chaperone activity of the N
protein revealed no change in duplex band intensity after incubation for 1.5-hours for
SARS-CoV-2 and no apparent duplex band for SARS-CoV s2m (data not shown). To
verify that the N protein did not have an effect on SARS-CoV s2m conversion from the
kissing dimer to duplex conformation at physiological temperatures, we also performed
studies at 37 °C. Similar to the results seen in Figure 5.7A, no distinct dimer band was
present for SARS-CoV s2m following incubation with the N protein (Figure 5.7B).
However, the higher temperature accelerated the spontaneous conversion from kissing
complex to duplex conformations for SARS-CoV-2 s2m, as bands corresponding to
extended duplex are clearly apparent even in the absence of the N protein (Figure 5.7B,
left panel, arrow 3).
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Figure 5.7: Conversion of the SARS-CoV-2 s2m kissing complex to a stable, extended duplex by the viral N
protein. Both SARS-CoV and SARS-CoV-2 s2m elements were incubated in the presence of 1 mM MgCl2 for
1-hour, followed by addition of the N protein in a 1:2 ratio and additional incubation for 30-minutes at 22
°C (A) or 37 °C (B). Samples were split and electrophoresed in TBE and TBM nondenaturing gels. Control
samples were included in which both s2m elements were incubated in the presence of BSA in a 1:2 ratio
(lanes 3 and 6). Monomeric conformations are denoted by arrow 1, kissing dimer conformations by arrow
2, and extended duplex structures by arrow 3.

The finding that the SARS-CoV s2m kissing dimer is not converted to a stable
duplex conformation is surprising considering that the two sequences differ only by two
nucleotides (Table 5.1; Figures 5.6A and 5.6B). In these experiments, we used the SARSCoV-2 N protein, whose RNA-binding domain has a high sequence and structural
homology with that of the SARS-CoV N protein (Figure 5.8) (Huang et al., 2004; Kang et
al., 2020). Furthermore, nondenaturing PAGE binding studies demonstrated that the
SARS-CoV-2 N protein is bound by both the SARS-CoV and SARS-CoV-2 s2m elements
(Figure 5.9A, arrows 2-4). Control experiments subsequently demonstrated that the N
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protein binds specifically to these particular RNA stem loop structures, as it did not bind
to the SARS-CoV-2 5’ UTR SL2 and SL3 stem loops and bound with lower affinity to the
SARS-CoV-2 3’ UTR pseudoknot (PK) stem loop (Figure 5.9B). Given that the SARSCoV s2m is bound by the SARS-CoV-2 protein, we proposed that its lack of conversion
from the kissing dimer to a duplex conformation is likely due to the fact that its structure
lacks a large internal bulge in its stem loop (compare Figures 5.6A and 5.6B), which makes
it too stable for N protein unfolding. Indeed, previous studies of the HIV-1 N protein
chaperone activity suggested that the presence of bulges in the lower stem of the
monomeric stem loop is essential for the conversion of the kissing dimer to duplex
conformation (Jalalirad et al., 2012; Song et al., 2008).
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Figure 5.8: Sequence and structure comparison between SARS-CoV and SARS-CoV-2 N protein RNA-binding domains
(RBDs). Sequences were compared using MEGA X molecular alignment software (A). Structural alignment of SARSCoV N protein RBD (PDB: 1SSK) and SARS-CoV-2 N protein RBD (PDB: 6M3M) was performed using PyMol
visualization software (B) (Huang et al., 2004; Kang et al., 2020).
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Figure 5.9: Binding of the s2m elements to the viral SARS-CoV-2 N protein. SARS-CoV and SARS-CoV-2
s2m elements were incubated in the presence of 1 mM MgCl2 and the SARS-CoV-2 N protein in a 1:2 ratio
for 1-hour, followed by electrophoresing in a TBE nondenaturing gel (A). The formation of s2m:N protein
complex bands are indicated by arrows 2-4. Control samples of each s2m element were incubated in the
presence of BSA at a 1:2 ratio (lanes 7 and 8). N protein binding to SL2, SL3, and PK stem-loop elements of
the SARS-CoV-2 genome (B) were performed as controls to show RNA element specificity. Complex
formation to the PK stem loop element is denoted with an asterisk (*).

Chapter 5.4 The s2m Element of SARS-CoV-2 Interacts with Host Cellular miRNA1307-3p. In recent years, it has become increasingly evident that coronaviruses utilize
various host cell components for their own replicative benefit (de Wilde et al., 2018;
Enjuanes et al., 2006; Laise et al., 2020). RNA viruses in general may also harbor the ability
to hijack the functions of host cellular miRNAs to their advantage. The HCV virus, for
example, sequesters miRNA-122 in order to stabilize its RNA and facilitate replication
(Jopling et al., 2005; Shimakami et al., 2012). Similarly, hijacking of miRNA-142-3p by
the North American eastern equine encephalitis virus (EEEV) results in repression of
innate immune responses and subsequently, increased severity of disease (Trobaugh et al.,
2014). In most circumstances, the location of naturally-occurring miRNA-binding sites
occurs within the 3’ UTR of viral RNA genomes (Trobaugh & Klimstra, 2017).
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Bioinformatic analysis of the SARS-CoV-2 genome by us and others has revealed
various potential miRNA-binding sites within both the 5’ and 3’ UTRs, including two
potential binding sites for host cellular miRNA-1307-3p within the s2m element (Arisan et
al., 2020; Chan et al., 2020; Vahed et al., 2020). Under normal cellular conditions, miRNA1307-3p is predicted to regulate the translation of various interleukins (IL18, CCLS),
interleukin receptors (IL6R, IL10RA, IL10RB, IL2RB, IL17RA, IL12RB2), and interferon
alpha receptor (IFNAR). Upregulation of these factors have been linked to the onset of the
“cytokine storm” found in severe COVID-19 patients (Mehta et al., 2020). Due to the
potential relevance of miRNA-1307-3p to the severity of the disease, as well as the
potential for multiple binding sites within the s2m element, we sought to characterize their
interactions, and moreover, to determine if dimerization of the s2m element affects these
interactions.
Binding studies were completed for SARS-CoV and SARS-CoV-2 using
nondenaturing TBE gel electrophoresis to examine the proposed interactions of miRNA1307-3p to the s2m element (Figure 5.10). Samples were incubated in the presence of 1
mM MgCl2 and increasing ratios of s2m RNA:miRNA-1307-3p for 1-hour at room
temperature, after which the samples were separated and run on a TBE nondenaturing gel.
Two upper bands (Figure 5.10, lanes 6 and 7, arrows 4 and 5) that increase in intensity
with the concomitant decrease in intensity of the monomer s2m band (Figure 5.10, lanes
6 and 7, arrow 2) are present at all miRNA-1307-3p concentrations investigated for SARSCoV-2. We assign these bands to the complex of the SARS-CoV-2 s2m element with one
(arrow 4) and two (arrow 5) miRNA-1307-3p molecules, respectively. Similarly, SARSCoV s2m also forms a complex with two miRNA-1307-3p molecules, as a clear upper band

82

is present in the presence of increasing miRNA concentrations (Figure 5.10, lanes 2 and
3, arrow 5). The band corresponding to the complex formed by SARS-CoV s2m and a
single miRNA-1307-3p molecule (Figure 5.10, lanes 2 and 3, arrow 4) is not clearly visible
in this gel because it is under the detection limit. The propensity of each s2m element to
interact with multiple copies of miRNA-1307-3p as compared to a single molecule is likely
due to a cooperative binding mechanism in which binding of the first miRNA-1307-3p
molecule causes the s2m element to unfold from its canonical stem-loop conformation,
exposing the binding site for the second miRNA-1307-3p molecule. Notably, the bands
corresponding to the complexes formed by SARS-CoV-2 s2m with miRNA-1307-3p are
more intense compared to those of SARS-CoV (Figure 5.10, arrows 4 and 5).

Figure 5.10: Interaction of the SARS-CoV and SARS-CoV-2 s2m elements with cellular miRNA-1307-3p.
Both s2m elements at concentrations of 1 µM were incubated with 1 mM MgCl2 and miRNA-1307-3p at
increasing 1:0, 1:1, and 1:2 ratios (lanes 1-3 and 5-7) for 1-hour. Samples were analyzed by TBE
nondenaturing PAGE. Each s2m element was also slow-annealed (S.A.) with miRNA-1307-3p at a 1:2 ratio
(lanes 4 and 8). Lane 9 contains the mature miRNA-1307-3p marker. Monomeric miRNA-1307-3p
conformations are denoted by arrow 1, monomeric s2m by arrow 2, dimeric miRNA-1307-3p by arrow 3,
s2m:miRNA-1307-3p by arrow 4, and s2m:miRNA-1307-3p(2) by arrow 5.

These differences in the binding of the SARS-CoV and SARS-CoV-2 s2m elements
to miRNA-1307-3p cannot easily be explained based on the two-nucleotide difference
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between the sequences. The first binding site for miRNA-1307-3p in SARS-CoV has a
single nucleotide difference from that of SARS-CoV-2, which results in a G:U base pair
being replaced with a G:C base pair in its complex with the miRNA (U5C, Figures 5.6A
and 5.6B), and a predicted difference in the binding free energy of only 2.6 kcal/mol as
determined by the RNAstructure software (Reuter & Mathews, 2013). The second binding
site for miRNA-1307-3p differs in the nucleotide at position 31, a guanine residue in
SARS-CoV and a uracil residue in SARS-CoV-2. However, given its location in an internal
bulge, the predicted binding free energy is the same for both s2m elements and is not
predicted to make a difference in miRNA-1307-3p binding at this site. Thus, we
hypothesized that the difference in miRNA-1307-3p binding between SARS-CoV and
SARS-CoV-2 s2m elements is due to their different dimerization properties. We proposed
that, when in its monomeric conformation, SARS-CoV and SARS-CoV-2 s2m elements
bind similarly to miRNA-1307-3p, but that these interactions are inhibited by the s2m
kissing dimer formation.
To test this hypothesis, both SARS-CoV and SARS-CoV-2 s2m samples were
incubated with increasing concentrations of miRNA-1307-3p in the absence of MgCl2,
where both elements exist in their monomeric state, followed by electrophoresing on a TBE
gel (Figure 5.11, lanes 1-6). For comparison, two samples were incubated in the presence
of 1 mM MgCl2, conditions in which SARS-CoV s2m exists mostly as a kissing dimer,
whereas SARS-CoV-2 s2m is mostly monomeric (Figure 5.4, right panel). As predicted,
the affinity for miRNA-1307-3p does not seem to differ between the two monomeric s2m
elements (Figure 5.11, compare lanes 2-3 with lanes 5-6), as evident by comparable
intensities of the bands corresponding to their complex formed with two miRNA molecules
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(Figure 5.11, arrow 5). However, similar to Figure 5.10, incubation in the presence of
Mg2+ ions, the band corresponding to the SARS-CoV s2m complex with two miRNA1307-3p molecules is less intense than that of SARS-CoV-2 s2m (Figure 5.11, compare
lanes 7 and 8). We attribute these differences to the equilibria that exists between
monomeric and dimeric conformations of each s2m element in the presence of Mg2+ ions
(Figure 5.4, right panel). SARS-CoV-2 s2m exists primarily in its monomeric state,
allowing for increased binding to the miRNA. In contrast, SARS-CoV s2m exists primarily
in a kissing dimer complex in the presence of Mg2+ ions, potentially inhibiting its
interactions with the miRNA-1307-3p. Upon chelation of the ions by EDTA, both s2m
elements dissociate to be fully monomeric, allowing increased binding to miRNA-13073p and resulting in the increased complex band intensities seen, as compared to those
incubated in the absence of any MgCl2 (Figure 5.11, compare lanes 1-6 with lanes 7 and
8). Thus, we conclude that the s2m dimerization affects its interactions with miRNA-13073p.

85

Figure 5.11: Dimerization of the s2m element affects miRNA-binding ability. SARS-CoV and SARS-CoV-2
s2m elements were incubated in the presence of miRNA-1307-3p at 1:0, 1:1, and 1:2 ratios in the absence of
MgCl2 (lanes 1-6) and electrophoresed on a nondenaturing TBE gel. Control samples were included in which
each s2m element were incubated with 1:2 miRNA-1307-3p in the presence of 1 mM MgCl2 (lanes 7 and 8).
Monomeric miRNA-1307-3p conformations are denoted by arrow 1, monomeric s2m by arrow 2, dimeric
miRNA-1307-3p by arrow 3, s2m:miRNA-1307-3p by arrow 4, and s2m:miRNA-1307-3p(2) by arrow 5.
Higher order complexes between SARS-CoV s2m and miRNA-1307-3p are denoted by arrow 6.

Chapter 5.5 Discussion. While the specific role of the s2m element in coronaviruses
remains unresolved, it has been proposed to be involved in viral replication, hijacking of
host protein synthesis, and RNA interference pathways (Goebel et al., 2004; Robertson et
al., 2005; Tengs et al., 2013). Here, we demonstrate for the first time the ability of the
SARS-CoV-2 s2m element to participate in genome dimerization via the formation of an
intermediate kissing dimer which is converted to a stable duplex conformation. Moreover,
our results suggest that while the SARS-CoV-2 s2m element may spontaneously convert
to the thermodynamically stable duplex over time, the viral N protein exhibits chaperone
activity to accelerate this conversion. In contrast, while the SARS-CoV s2m element
readily forms kissing dimers, these complexes are not converted to the stable duplex
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conformation, even in the presence of the N protein. The conversion mechanism discovered
here for SARS-CoV-2 s2m is similar to that seen in HIV-1, in which viral N protein acts
as a molecular chaperone to convert transient kissing dimer complexes into a stable,
extended duplex structures (Cruceanu et al., 2006; Feng et al., 1997; Muriaux et al., 1996).
This process in the Retroviridae family of viruses, to which HIV-1 belongs, is believed to
facilitate dimerization of two genomic RNA copies for packaging in the virion, a function
which does not occur in Coronaviridae viruses. However, an identical mechanism of
monomeric stem loop destabilization and conversion to thermodynamically stable duplex
structures by the N protein has been demonstrated with HCV, another single-stranded,
positive-sense RNA virus (Cristofari et al., 2004; Darlix et al., 1995; Shetty et al., 2010).
Furthermore, the mechanism in HCV was proposed to modulate the interactions of the
dimer initiation site with additional open reading frame stem loops, which are essential for
RNA replication, suggesting similar functions within SARS-CoV-2 (Friebe et al., 2005;
Shetty et al., 2013). It is possible that in SARS-CoV-2, this dimerization mechanism may
also function in genome frameshifting and subsequent sgRNA and gRNA synthesis. A
three-stemmed pseudoknot structure within the open reading frame (ORF) of the SARSCoV genome has been shown previously to act as a ribosomal frameshift stimulating signal
(Plant et al., 2005; Su et al., 2005). One of the stem loop structures within this signal
contains a 6-nucleotide palindrome within its terminal loop region which has been
demonstrated to form homodimeric kissing interactions, and disruption of these
interactions resulted in reduced frameshifting (Ishimaru et al., 2013). Thus, it is possible
that the s2m dimerization may facilitate the alignment of multiple gRNA molecules, in
coordination with the kissing loop interactions in the ORF, to allow for proper
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frameshifting and RNA synthesis. Lastly, we speculate on the role of genome dimerization
with respect to recombination events. The origin of the SARS-CoV-2 virus is proposed to
be the result of homologous recombination between bat and pangolin coronaviruses, likely
triggering the cross-species transmission to humans (Lam et al., 2020; Wong et al., 2020).
High recombination rates among coronaviruses have been well documented, though the
exact mechanism by which this occurs is unknown (Terada et al., 2014). Similarly, this
high rate of recombination has been studied extensively in other viral families, such as
Astroviridae, Caliciviridae, and Picornaviridae (Coyne et al., 2006; King et al., 1982;
Wohlgemuth et al., 2019). Interestingly, all of these viral families also contain the
conserved s2m element within their 3’ UTR (Jonassen et al., 1998; Kofstad & Jonassen,
2011; Tengs et al., 2013). Given the high degree of similarities between recombination
events and conservation of the s2m element within Coronaviridae, Astroviridae,
Caliciviridae, and Picornaviridae families, which we have demonstrated to form
homodimeric kissing complex and extended duplex structures, we speculate whether this
element may be involved in genomic dimerization and potentially contribute to subsequent
homologous recombination events. However, further studies are required to explore such
functions.
Our study subsequently investigated the proposed hijacking of cellular miRNA1307-3p by the s2m element of SARS-CoV-2 (Arisan et al., 2020; Chan et al., 2020; Vahed
et al., 2020). Indeed, we have shown for the first time that SARS-CoV-2 s2m binds multiple
copies of miRNA-1307-3p, and furthermore, this interaction is affected by the state of s2m
dimerization. The role of host cellular miRNA hijacking by viruses has been demonstrated
extensively in previous studies, typically benefitting the viral life cycle. Bovine viral
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diarrhea virus, for instance, interacts with miRNA-17 upon infection, resulting in enhanced
replication, translation, and genomic RNA stability (Scheel et al., 2016). Similarly,
miRNA-133a is bound by the 3’ UTR of the Dengue virus, essentially “sponging” it from
its normal function of regulating the polypyrimidine tract-binding (PTB) protein (Castillo
et al., 2016). This interaction results in an upregulation of the PTB protein, leading to
increased viral replication and translation. We propose a similar mechanism with SARSCoV-2 hijacking cellular miRNA-1307-3p through its s2m element, resulting in
upregulated expression levels of its target mRNAs, including those that encode for various
interleukins and interleukin receptors linked to the “cytokine storm” (Mehta et al., 2020).
Furthermore, we contemplate the implications of a fine-tuned molecular switch from s2m
element dimerization to miRNA-1307-3p binding in the viral life cycle. Given the
unusually long delay in symptom development, we speculate whether SARS-CoV-2 s2m
dimerization is important for initial RNA replication and protein synthesis, followed by a
switch to its miRNA-1307-3p binding function, activating immune response pathways.
Altogether, the results of this study implicate the highly conserved s2m element of SARSCoV-2 as a potentially significant molecular target for antiviral therapeutics for COVID19 as well as future coronavirus-related disease outbreaks.
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Chapter 6: Conclusions and Future Work
The research encompassed in this dissertation focused primarily on the role of RNA
structure and its function in relation to various neurodegenerative and infectious diseases.
Conventional belief about the role of RNA is that it acts as an intermediate step in the
central dogma of molecular biology, converting DNA to the protein building blocks of life
(Crick, 1970). However, the knowledge surrounding RNA and its functions has evolved
over the years, leading researchers to now portray RNA, both coding and noncoding, as
vital components of gene expression, nucleic acid processing, ribosomal assembly, and
ribonucleoprotein complex formation (Li & Liu, 2019). This work has focused on the
characterization of both coding and noncoding RNA secondary structures, as well as their
interactions with RNA-binding proteins, allowing us to speculate on potentially pathogenic
mechanisms which could ultimately aid in future therapeutic drug development.
Our first study focused on the characterization of secondary structures within the
guanine-rich pre-miRNA-1229, whose mature miRNA product is upregulated in the
presence of a single nucleotide mutation correlated to AD (Ghanbari et al., 2016). We
hypothesized that this mutation could lead to the dysregulation of pre-miRNA-1229
secondary structure equilibrium, ultimately affecting miRNA processing and subsequent
expression of target mRNAs whose products are involved in AD etiology. Our studies
revealed that an equilibrium existed between canonical stem loop and noncanonical GQ
structures within pre-miRNA-1229, and that this equilibrium was subsequently shifted in
the AD-associated variant towards the stem loop structure. These results led us to speculate
that the shift in equilibrium results in upregulation of the mature miRNA-1229-3p product,
potentially downregulating SORL1 protein expression and increasing the production of
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amyloidogenic Aβ42 seen in AD patients. We propose that the GQ structure found within
pre-miRNA-1229 is an attractive therapeutic target for hindering AD pathogenesis. Future
studies will examine this mechanism in various other guanine-rich pre-miRNAs, adding to
the breadth of knowledge focused on how structural equilibrium within noncoding premiRNAs could indirectly affect key processes in the regulation of mRNA expression.
Our second study investigated the role of FMRP in the miRNA biogenesis pathway,
given previous findings that it interacts with RNAs of pre-miRNA length as well as distinct
components of the pathway, including AGO2 and Dicer (Cheever & Ceman, 2009;
Muddashetty et al., 2011). While we initially sought to determine whether GQ structure
formation with pre-miRNA-125a played a role in this processing, characterization of the
sequence revealed that it folded primarily into a stem loop conformation. We instead
shifted focus to investigate the role of FMRP phosphorylation in pre-miRNA-125a
processing, leading to the intriguing finding that FMRP ISO1 (S500D), even in the absence
of Dicer, resulted in enzymatic cleavage. Control studies demonstrated that this enzymatic
activity was not limited to just pre-miRNA-125a, although direct evidence of a novel
FMRP function was inconclusive. Further studies are necessary to investigate this
potentially significant finding, including mutational studies to deduce the location of
enzymatic activity. These studies will focus on various truncations of the FMRP protein,
including mutations which will exclude entire KH domains essential for RNA-binding, as
well as investigating the effect of the well-document KH2 variable loop truncation within
the most predominant isoforms of FMRP (Brackett et al., 2013). This work has the potential
to reveal critical information about the functional roles that FMRP plays in mRNA
processing, shuttling, and regulation of translation.
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Previous work in the lab had determined that the RNA-binding protein FUS,
implicated in ALS pathogenesis, binds to neuronal GQ structures within PSD-95 and
Shank1 neuronal mRNAs. Our third study sought to determine whether these structures
were required for binding to occur, as well as the potential implications in ALS
pathogenesis. Indeed, mutations that disrupt GQ formation within neuronal PSD-95 and
Shank1 mRNAs, whose protein products are important for synaptic plasticity and
maintenance, resulted in abolished binding by FUS, suggesting that these structures are per
se sufficient for the interaction to occur. Furthermore, investigation of the effect of an ALSlinked FUS mutant in which the C-terminal region of the protein is truncated resulted in
abolished binding, suggesting that the RGG3 domain of FUS is responsible for the binding
to GQ structures. We speculate that the presence of these GQ structures within certain
neuronal mRNAs is vital for nucleocytoplasmic shuttling to synapses by FUS for local
translation, and that this function is inhibited in a certain ALS-linked FUS mutation,
resulting in abnormal spine density and morphology. Future work will extend these
findings to investigate the role of various other ALS-linked FUS mutations, as well as a
potential synergistic role of FMRP is nucleocytoplasmic shuttling, in order to gain a better
understanding of the mechanism in ALS etiology.
Finally, our fourth study investigated the role of RNA structure and function in
relation to the ongoing COVID-19 pandemic. Conserved within the 3’ UTR of the SARSCoV-2 genome is a 41-nucleotide s2m element suggested to play roles in viral replication,
hijacking of host protein synthesis, and RNA interference pathways (Tengs & Jonassen,
2016). We proposed that this element forms homodimeric RNA-RNA kissing dimer
interactions via a 4-nucleotide palindrome within its terminal loop region which is
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converted to a thermodynamically stable extended duplex conformation by the viral N
protein. Indeed, SARS-CoV-2 s2m exists in equilibrium between monomeric and multiple
dimeric conformations, and conversion from the intermediate kissing dimer to the extended
duplex is aided by chaperone activity of the N protein. Furthermore, our results provide
evidence that the s2m element of SARS-CoV-2 binds to multiple copies of cellular
miRNA-1307-3p, an interaction mediated by s2m dimerization. Our results suggest a
potential molecular switch in the viral life cycle of SARS-CoV-2 and implicate the s2m
element as a potential therapeutic target for future drug design studies. Further studies will
focus on the effect of rapidly evolving mutations within the s2m element and their effect
on both dimerization and miRNA binding in order to better understand the importance of
these novel functions in relation to the viral life cycle.
Taken together, the results of this dissertation further highlight the importance of
gaining increased insight into the relationship between RNA structure and function in
relation to the pathogenesis of both neurodegenerative and infectious diseases. We
demonstrate in the various studies that intrinsic dysregulations, including shift in secondary
structure equilibrium, disease-associated mutations, or natural genetic evolution, hinder
key processes and potentially aid in disease etiology. Overall, gaining a better
understanding of the relationships between RNA structures and their functions in
fundamental molecular mechanisms is crucial for future therapeutic drug development.
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Chapter 7: Materials and Methods
Chapter 7.1 In Vitro RNA Synthesis RNA oligonucleotide sequences (Tables 2.1, 3.1,
and 4.1) were produced by in vitro transcription reactions using T7 RNA polymerase
(synthesized in-house), following the procedure by Milligan and Uhlenbeck (Milligan &
Uhlenbeck, 1989). The DNA templates for each sequence were chemically synthesized by
TriLink Biotechnologies, Inc. RNA oligonucleotides were purified by 20% 8 M urea
denaturing polyacrylamide gel electrophoresis (PAGE) and electrophoretic elution,
followed by extensive dialysis against 10 mM cacodylic acid, pH 6.5. The concentration
of each oligonucleotide was measured at 260 nm using a NanoDrop 2000 UV-Vis
spectrophotometer (Thermo Fisher Scientific) and their purity was checked by denaturing
gel electrophoresis. Chemically synthesized RNA oligonucleotides were purchased from
Dharmacon, Inc. and resuspended in 10 mM cacodylic acid, pH 6.5.
Chapter 7.2 One-Dimensional 1H NMR Spectroscopy One-dimensional (1D) proton
(1H) NMR spectroscopy experiments were performed on a 500 MHz Bruker AVANCE
spectrometer (Bruker Corporation) at 19-25 °C using Topspin 3.2 software. Water
suppression was carried out by using the Watergate pulse sequence (Piotto et al., 1992).
Oligonucleotide samples with concentrations ranging from 100-300 μM were prepared in
a volume of 250-290 μL 10 mM cacodylic acid, pH 6.5, in a 90:10 ratio of H2O:D2O. Imino
proton resonances were monitored in the 10-14.5 ppm region of the resulting spectra. GQ
formation was observed by titrating increasing concentrations of KCl from a 2 M stock
solution to each sample. Samples containing 150 mM KCl were subsequently annealed at
95 °C for 5 min and cooled on the bench for 15 min. Time-dependent NMR spectroscopy
studies were conducted following the addition of 1 mM MgCl2 to each sample and
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incubating at 37 °C, while acquiring spectra over time, in order to monitor structural
equilibrium.
Chapter 7.3 Circular Dichroism Spectroscopy Circular dichroism (CD) spectroscopy
experiments were recorded on a Jasco J-810 spectropolarimeter (JASCO International Co.,
LTD) at 25 °C. RNA oligonucleotide samples were prepared in 10 mM cacodylic acid, pH
6.5, to a final RNA concentration of 10 μM and final volume of 200 μL in a quartz cuvette
(Starna Cells) with a 1 mm path-length. GQ formation was monitored by titrating
increasing amounts of KCl from a 2 M stock solution to each sample and subsequently
annealing the sample at 95 °C for 5 min once a final KCl concentration of 150 mM was
reached. Spectra were measured between 200 and 300 nm and corrected for solvent
contributions. Each spectrum was scanned seven times with a 1 s response time and a 2 nm
bandwidth. CD spectroscopy experiments were performed in duplicate (n = 2) for each
RNA.
Chapter 7.4 UV Spectroscopy Thermal Denaturation Thermal denaturation
experiments were performed using a Varian Cary 3E UV/Vis spectrophotometer (Agilent
Technologies) equipped with a Peltier cell. RNA samples were annealed in 10 mM
cacodylic acid, pH 6.5, containing 100-150 mM KCl. Samples were heated from 25 to 95
°C at a rate of 0.2 °C min−1, recording points every 1 °C at 295 nm, a wavelength
previously identified to be sensitive to GQ dissociation (Mergny et al., 1998).
Hypochromic transitions representing GQ dissociation were identified and fit using
Equation (1) (Menon et al., 2008):
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where AU and AF represent the absorbance of the unfolded and native GQ RNA,
respectively, ΔH° and ΔS° are the Van’t Hoff thermodynamic properties, and R is the
universal gas constant. Thermal denaturation experiments were performed at RNA
concentrations ranging from 5-50 µM, followed by plotting of melting temperature (Tm)
values against RNA concentration to determine if the structures fold into intermolecular or
intramolecular conformations. The Tm of an intermolecular GQ structure depends on total
RNA concentration and can be determined using Equation (2) (Zhang et al., 2014):
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where [RNA]t represents total RNA concentration and n is the number of RNA strands.
Conversely, intramolecular GQ structures formed within a single strand of RNA (n = 1) is
independent of the total RNA concentration and can be determined using Equation (3)
(Zhang et al., 2014):
4
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Chapter 7.5 Nondenaturing Polyacrylamide Gel Electrophoresis RNA samples were
prepared with varying KCl or MgCl2 concentrations and a constant RNA concentration of
1-20 μM, followed by annealing for 5 min at 95 °C and either slow cooling to room
temperature or immediate snap-cooling on dry ice. Samples were run on 12-20%
polyacrylamide Tris-Boric Acid-EDTA (TBE) or Tris-Boric Acid-Magnesium (TBM) gels
in their respective buffers. TBM gels and buffers each contained 5 mM MgCl2. All gels
with [RNA] greater than 5 µM were visualized using an AlphaImager (ProteinSimple) by
UV shadowing at 254 nm (Hendry & Hannan, 1996). Lower [RNA] samples were
subsequently stained in either EtBr or cyanine SYBR Gold dye and visualized by UV
transillumination. To monitor GQ formation, gels were stained in N-methyl mesoporphyrin
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IX (NMM), a GQ-specific fluorescent probe (Arthanari et al., 1998). Peptide binding gels
were performed in a similar manner, with RNA samples annealed at 95 °C, cooled to room
temperature, and incubated with peptide for 15 minutes prior to sample loading. miRNA
binding gels were performed by annealing samples at 95 °C and immediately snap-cooling
on dry ice. Once thawed, MgCl2 and respective miRNA concentrations were added to
samples and allowed to incubate for 1-hour prior to loading gel. Gel electrophoresis
experiments were performed in triplicate (n = 3) for each RNA.
Chapter 7.6 Expression and Purification of Recombinant FMRP Isoforms The peptide
corresponding to the arginine-glycine-glycine (RGG) region of FMRP was chemically
synthesized by the Peptide Synthesis Unit at the University of Pittsburgh Center for
Biotechnology and Engineering. Full-length FMRP Isoform 1 (ISO1) and its
phosphomimic (ISO1 (S500D)) were expressed and purified as described by Evans and
Mihailescu (Ceman et al., 2003; Evans & Mihailescu, 2010). Briefly, recombinant pET21a
plasmids encoding FMRP ISO1 and FMRP ISO1 (S500D) fused with a 6x histidine Cterminal tag were transformed into Rosetta 2(DE3)pLysS E. coli competent cells
(Novagen). Cells were inoculated on Luria-Bertani (LB)-agar media containing ampicillin
(Amp) and chloramphenicol (Chl) and incubated overnight at 37 °C. Single colonies were
selected and grown in 250 mL of LB-Amp-Chl media for 12-hours at 37 °C. In sterile, 2 L
Erlenmeyer flasks, 25 mL of overnight culture was combined with 475 mL LB-Amp-Chl,
followed by incubation at 37 °C and 250 rpm until an OD600 of 0.8 was reached. To induce
expression, 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to each flask
and incubated for an additional 12-hours at 25 °C. Following centrifugation and decanting
of supernatant, cells were harvested and lysed by sonication. FMRP ISO1 and FMRP ISO1
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(S500D) were purified by low-pressure liquid chromatography (LPLC) using a Ni-NTA
resin (Qiagen). Purified proteins were concentrated, dialyzed against decreasing
concentrations of imidazole, and final concentrations of FMRP were determined by
measuring absorbance on a NanoDrop 2000 UV-Vis spectrophotometer (Thermo Fisher
Scientific) at 280 nm and using an extinction coefficient of 46,370 M-1 cm-1. Purity of
fractions were determined by sodium dodecyl sulfate PAGE (SDS-PAGE).
Chapter 7.7 In Vitro Cleavage Assays RNA samples at a concentration of 1 µM were
prepared in buffer consisting of 10 mM Tris (pH 7.4), 1 mM MgCl2, and 0.15 mM ATP.
Samples were subsequently incubated at 37 °C in the presence of either recombinant Dicer
(Genlantis Inc.), FMRP ISO1, FMRP ISO1 (S500D), or a combination of the proteins.
Aliquots were taken at 10- to 30-minute time increments and proteinase K was added to
digest proteins. Samples were subsequently electrophoresed on 15% nondenaturing or 20%
denaturing polyacrylamide TBE gels to analyze enzymatic cleavage products.
Chapter 7.8 Proteolytic Digest and ESI-QToF-MS In-gel digest was performed
by electrophoresing FMRP ISO1 (S500D) using SDS-PAGE and manually excising target
bands. Excised gel pieces were then washed extensively with 100 mM ammonium
bicarbonate in 50% acetonitrile, followed by shaking at 300 rpm and 25 °C for a total of
45-minutes. Similar to the protocol described above for in-solution digest, DTT and IAM
were added to samples, followed by shaking at 56 °C and 37 °C, respectively, for 1-hour.
Gel plugs underwent additional washes in 100 mM ammonium bicarbonate and 100%
acetonitrile, followed by drying to remove supernatant. Trypsin or trypsin/LysC proteases
were added as described previously to 20 µL of 100 mM ammonium bicarbonate and
samples were incubated at 37 °C and 300 rpm overnight. Samples were washed in elution
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buffer (0.1% formic acid in ultrapure (18.2 MΩ) deionized water), dried, and reconstituted
in 50 µL of elution buffer for analysis.
In-solution digest of FMRP ISO1 (S500D) was performed by combining 20 µg of
protein with 20 µL 2,2,2-trifluoroethanol (TFE) and 2.5 µL dithiothreitol (DTT), followed
by heating for 45-minutes at 56 °C and 300 rpm. Subsequently, 10 µL of iodoacetamide
(IAM) was added and samples were incubated in the dark for an additional 45-minutes at
room temperature and 300 rpm. Samples were dried for 45-minutes at 45 °C using a
SPD1010 Integrated SpeedVac System (Thermo Fisher Scientific), followed by
reconstitution in 50 µL ammonium bicarbonate. Either trypsin or trypsin/LysC protease
(Pierce) was added in a 20:1 substrate:enzyme ratio and samples were incubated for 18hours at 37 °C and 300 rpm. Formic acid was added to stop the reaction and samples were
dried as previously described, followed by reconstitution in 20 µL 0.1% formic acid in
ultrapure (18.2 MΩ) deionized water and resuspension for 18-hours by shaking at 300 rpm.
Liquid-chromatography mass spectrometry (LC-MS) analysis of digested proteins
was performed using an Agilent 6530 Accurate-Mass quadrupole time-of-flight (QTOF)
mass spectrometer (Agilent Technologies). The system was equipped with an electrospray
ionization (ESI) injection source and corresponding Agilent MassHunter Workstation
software (Agilent Technologies). Samples were passed through an Aeris 3.6 µm WidePore
XB-C18 (150 x 2.1 mm) column (Phenomenex) prior to injection into the mass
spectrometer. Column was rinsed with 50/50 aqueous (95:5 ultrapure (18.2 MΩ) deionized
water:acetonitrile with 0.1% formic acid) / organic (80:10:10 acetonitrile:TFE:ultrapure
(18.2 MΩ) deionized water) phases at 0.450 mL/min to equilibrate the system. A custom
55-minute proteomic method was developed for data analysis. Resulting data files were
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extracted, validated, and searched against the Swiss Protein Data Bank using Spectrum
Mill MS Proteomics Workbench software (Agilent Technologies) to determine the identity
of digested protein samples.
Chapter 7.9 Expression and Purification of Recombinant FUS Isoforms The peptide
corresponding to the C-terminal RGG domain of FUS (RGG3) was chemically synthesized
by the Peptide Synthesis Unit at the University of Pittsburgh Center for Biotechnology and
Engineering. Plasmids encoding wild-type and mutant (R495X) full-length GST-FUS
fusion proteins were generously provided by Dr. Daryl Bosco (University of Massachusetts
Medical School) and transformed into Rosetta 2(DE3)pLysS E. coli competent cells
(Novagen). Cells were inoculated on LB agar plates containing 200 µg/mL Amp and 15
µg/mL Chl, followed by overnight incubation at 37 °C. A single colony was added to 5 mL
of LB-Amp-Chl media and incubated at 37 °C and 225 rpm for 6 hours. Starting culture
was then added to 150 mL LB-Amp-Chl media and incubated for 12-hours at 37 °C and
225 rpm. Two large cultures were subsequently prepared in 2 L Erlenmeyer flasks
containing 450 mL LB-Amp-Chl and 50 mL of overnight small culture, followed by
incubation at 37 °C at 225 rpm until an OD600 of 0.6-0.8 was reached. To induce
expression of GST-FUS fusion proteins, 0.3 mM IPTG and 0.1 mM ZnCl2 were added to
each 2 L Erlenmeyer flask and cultures were incubated for 22-hours at 30 °C. Cultures
were centrifuged at 6,000 rpm for 20 minutes at 4 °C, followed by decanting of supernatant
and harvesting of pelleted cells to be frozen overnight. Cell pellets were thawed and
resuspended in 30 mL of lysis buffer [50 mM Tris (pH 8.0), 1 mM DTT, 0.1 mM EDTA,
and a protease inhibitor cocktail tablet (Roche Diagnostics)] with 100 µg/mL RNase A.
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Cell samples were sonicated 3 times in 30 seconds intervals, followed by centrifugation at
13,000 rpm for 20 minutes at 4 °C and supernatant was collected.
The night prior to purification, 0.25 grams of glutathione-agarose resin (Thermo
Fisher Scientific) was pre-swelled in 50 mL sterile water and stored at 4 °C. Resin was
loaded into a column and pre-washed 5x with cold 50 mM Tris (pH 8.0), then transferred
to a 50 mL centrifuge tube containing supernatant to be incubated at 4 °C for 2 hours while
gently rocking. Mixture was centrifuged at 4,000 rpm for 5 minutes, followed by removal
of supernatant and addition of 30 mL cold 50 mM Tris (pH 8.0) to the centrifuge tube. The
resulting slurry was transferred to the column to be washed once with an additional 10 mL
of cold 50 mM Tris (pH 8.0). GST-FUS fusion proteins were eluted by gravity-flow
purification using 15 mL of freshly prepared elution buffer [10 mM glutathione, 1 mM
DTT, 500 mM Tris (pH 9.5) and collected into 5 separate fractions (3 mL each). The purity
of each fraction was determined by SDS-PAGE. Concentrations were calculated using a
NanoDrop 2000 UV-Vis spectrophotometer (Thermo Fisher Scientific) at 280 nm,
assuming 1 A280 = 0.5 mg/mL [FUS = 53 kDa (67%) / GST = 26 kDa (33%)].
Chapter 7.10 Steady-State Fluorescence Spectroscopy RNA was chemically
synthesized by Dharmacon Inc. to incorporate a 2-aminopurine (2AP) fluorescent analogue
within the loop region of proposed GQ structures (Table 2.1). Samples were prepared at a
concentration of 200 nM in 10 mM cacodylic acid, pH 6.5, in the presence of 150 mM KCl
and 5-fold excess (1 µM) Hepatitis C virus core peptide (HCV) or bovine serum albumin
(BSA) to reduce non-specific interactions of the FUS RGG3 peptide or full-length FUS
proteins, respectively. Experiments were performed on a Horiba Jobin Yvon Fluoromax-4
spectrophotometer (Horiba Scientific) equipped with a 150 W ozone-free xenon arc lamp
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and using a 3 mm path-length quartz cuvette (Starna Cells). Excitation wavelength was set
to 310 nm and emission was recorded from 330 – 450 nm, with monochromators set to 5
nm for both excitation and emission bandpass filters. FUS RGG3 peptide or full-length
FUS was titrated into the sample in 50 nM increments and emission was corrected for
buffer and free protein. Fluorescence intensity was recorded at 371 nm and normalized to
that of the free RNA, followed by plotting against peptide or full-length protein
concentration. To determine the dissociation constant (Kd) of peptide- or protein-RNA
complexes, the data were fit using Equation (4) (Menon et al., 2008):
I

𝐹 = 1 + HIJ − 1L ∗
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*
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where IF and IB represent steady-state fluorescent intensities of free and bound RNA,
respectively, [RNA]t is the total fixed RNA concentration, and [P]t is the total peptide or
protein concentration. Experiments were performed in triplicate and the reported Kd
represents an average of the three Kd values with the reported errors representing the
standard deviation.
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